{"content":"<li class=\"n-box-item date-title\" data-end=\"1393390799\" data-start=\"1393304400\" data-txt=\"Saturday, December 21, 2019\">Tuesday, February 25, 2014</li><li class=\"n-box-item sa-box-item\" data-id=\"1591683\" data-ts=\"1393373167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OVTI\" target=\"_blank\">OVTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591683-omnivision-a-part-of-googles-project-tango-shares-plus-3_2-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OmniVision a part of Google&#39;s Project Tango, shares +3.2% AH</a></h4><ul>\n<li>Ahead of its Thursday FQ3 report, OmniVision (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OVTI\" title=\"OmniVision Technologies, Inc.\">OVTI</a>) states it's working with Google to develop the <a href=\"https://seekingalpha.com/news/1581853-google-launches-3d-scanning-smartphone-initiative-himax-gains\" target=\"_blank\">recently-announced</a> Project Tango's 3D vision capabilities.</li>\n<li>Tango aims to enable Android phones that can track motion and create 3D maps of their surroundings. Potential applications including immersive gaming, indoor navigation, and 3D scanning.</li>\n<li>Two new OmniVision image sensors, the OV4682 and the OV7251, are part of Google's Tango development kit. The 4682 has a 4MP resolution, supports 90fps video capture, and can capture IR information (enables depth analysis), and the 7251 can capture VGA-resolution video at 100fps, while enabling low-light imaging and providing motion-tracking data.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1591683\" data-linked=\"OmniVision a part of Google&#39;s Project Tango, shares +3.2% AH\" data-tweet=\"$OVTI - OmniVision a part of Google&#39;s Project Tango, shares +3.2% AH https://seekingalpha.com/news/1591683-omnivision-a-part-of-googles-project-tango-shares-plus-3_2-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1591683-omnivision-a-part-of-googles-project-tango-shares-plus-3_2-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591673\" data-ts=\"1393372359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARO\" target=\"_blank\">ARO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591673-bloomberg-aeropostale-weighing-investment-sale-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Aeropostale weighing investment, sale options</a></h4><ul>\n<li>\n<a href=\"http://www.bloomberg.com/news/2014-02-25/aeropostale-said-to-work-with-barclays-on-buyout-firm-investment.html\" target=\"_blank\">Bloomberg reports</a> Aeropostale (NYSE:<a href=\"https://seekingalpha.com/symbol/ARO\" title=\"Aeropostale, Inc.\">ARO</a>) is working with Barclays to explore investment options such as a convertible note sale or a <a href=\"http://www.investopedia.com/terms/p/pipe.asp\" target=\"_blank\">PIPE transaction</a>, and is also \"weighing a straight-up sale.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1559061-aeropostale-considers-private-capital-raise\" target=\"_blank\">Reuters reported</a> two weeks ago the struggling apparel retailer is open to a PIPE deal. Activist investor Crescendo Partners has been pressing Aeropostale to look for a buyer.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/ARO\" title=\"Aeropostale, Inc.\">ARO</a> <font color=\"green\">+3.6%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1591673\" data-linked=\"Bloomberg: Aeropostale weighing investment, sale options\" data-tweet=\"$ARO - Bloomberg: Aeropostale weighing investment, sale options https://seekingalpha.com/news/1591673-bloomberg-aeropostale-weighing-investment-sale-options?source=tweet\" data-url=\"https://seekingalpha.com/news/1591673-bloomberg-aeropostale-weighing-investment-sale-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591633\" data-ts=\"1393371430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591633-weatherfords-weak-q4-overshadowed-by-plans-to-sell-non-core-businesses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford&#39;s weak Q4 overshadowed by plans to sell non-core businesses</a></h4><ul>     <li>Weatherford (NYSE:<a href=\"https://seekingalpha.com/symbol/WFT\" title=\"Weatherford International Ltd.\">WFT</a>) reports a <a href=\"https://seekingalpha.com/news/1591043-weatherford-international-ltd-eps-in-line-misses-on-revenue\" target=\"_blank\">wider Q4 unadjusted loss</a> and a Y/Y decline in revenue, but shares <font color=\"green\">+2.7%</font> AH on plans to sell non-core businesses.</li>     <li>WFT says it expects to sell its pipeline and specialty services, testing and production services, drilling fluids and wellheads businesses by the end of this year, and plans to spin off or take public its land drilling rig business in Q4 2014 or Q1 2015.</li>     <li>WFT, which said last month it would cut 7K jobs, says cash proceeds from the sale of the businesses would be used to pay down debt.</li>     <li>During Q4, North American operations, which accounts for ~45% of WFT's revenue, posted a 6.5% decrease in revenue; in the Middle East, North Africa and Asia, revenue fell 3.5%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1591633\" data-linked=\"Weatherford&#39;s weak Q4 overshadowed by plans to sell non-core businesses\" data-tweet=\"$WFT $WFTIQ - Weatherford&#39;s weak Q4 overshadowed by plans to sell non-core businesses https://seekingalpha.com/news/1591633-weatherfords-weak-q4-overshadowed-by-plans-to-sell-non-core-businesses?source=tweet\" data-url=\"https://seekingalpha.com/news/1591633-weatherfords-weak-q4-overshadowed-by-plans-to-sell-non-core-businesses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591593\" data-ts=\"1393370366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QEP\" target=\"_blank\">QEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591593-qep-resources-minus-13_3-percent-ah-on-big-q4-earnings-revenue-misses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QEP Resources -13.3% AH on big Q4 earnings, revenue misses</a></h4><ul>     <li>QEP Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/QEP\" title=\"QEP Resources, Inc.\">QEP</a>) <font color=\"red\">-13.3%</font> AH as <a href=\"https://seekingalpha.com/news/1590703-qep-resources-inc-misses-by-0_24-misses-on-revenue\" target=\"_blank\">Q4 earnings</a> and revenues both miss Wall Street expectations by wide margins.</li>     <li>Q4 net equivalent production decreased by 10% to 75.1B cfe in Q4 vs. 83.9B cfe in the year-ago quarter, and says severe winter weather had a \"meaningful negative impact\" on results.</li>\n<li>Sees QEP Energy total equivalent production of 283B-307B cfe in 2014; plans 2014 capex of $1.76B-$1.86B.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1591593\" data-linked=\"QEP Resources -13.3% AH on big Q4 earnings, revenue misses\" data-tweet=\"$QEP - QEP Resources -13.3% AH on big Q4 earnings, revenue misses https://seekingalpha.com/news/1591593-qep-resources-minus-13_3-percent-ah-on-big-q4-earnings-revenue-misses?source=tweet\" data-url=\"https://seekingalpha.com/news/1591593-qep-resources-minus-13_3-percent-ah-on-big-q4-earnings-revenue-misses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591543\" data-ts=\"1393369234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LJPC\" target=\"_blank\">LJPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591543-la-jolla-pharma-plus-22_4-percent-ah-wedbush-starts-at-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La Jolla Pharma +22.4% AH. Wedbush starts at Outperform.</a></h4><ul>\n<li>Wedbush's Liana Moussatos has <a href=\"http://www.streetinsider.com/Analyst+Comments/Wedbush+Starts+La+Jolla+Pharma+%28LJPC%29+at+Outperform%3B+Analyst+Comments/9215691.html\" target=\"_blank\">started coverage</a> on La Jolla Pharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LJPC\" title=\"La Jolla Pharmaceutical Co.\">LJPC</a>) with an Outperform and $27 PT.</li>\n<li>Moussatos sees a \"70% probability of a positive outcome\" for a Phase 2a trial of La Jolla's GCS-100 drug in March, and thinks the drug could see peak annual sales of $1B.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1591543\" data-linked=\"La Jolla Pharma +22.4% AH. Wedbush starts at Outperform.\" data-tweet=\"$LJPC - La Jolla Pharma +22.4% AH. Wedbush starts at Outperform. https://seekingalpha.com/news/1591543-la-jolla-pharma-plus-22_4-percent-ah-wedbush-starts-at-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/1591543-la-jolla-pharma-plus-22_4-percent-ah-wedbush-starts-at-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591453\" data-ts=\"1393368684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591453-sina-falls-hard-post-earnings-weibo-ad-sales-in-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sina falls hard post-earnings. Weibo ad sales in focus.</a></h4><ul>\n<li>Though <a href=\"https://seekingalpha.com/news/1587713-sina-minus-6_1-percent-ah-q1-guidance-in-line-no-weibo-ipo-announcement-yet\" target=\"_blank\">up 163% Y/Y</a>, Sina's (<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> <font color=\"red\">-9.3%</font>) Weibo ad sales were below Deutsche's forecast, says analyst <a href=\"http://www.streetinsider.com/Analyst+Comments/SINA+%28SINA%29+Price+Target+Reduced+to+%2487+at+Deutsche+Bank/9212809.html\" target=\"_blank\">Vivian Hao</a> while taking stock of the company's Q4 report. Hao, who maintains a Buy on Sina, also notes earnings would've missed estimates if not for a $19.5M change in the fair value of investor option liability for Alibaba's Weibo investment.</li>\n<li>At the same time, she's pleased ad sales tied to Alibaba's Taobao and Tmall sites grew 19% Q/Q to $23.8M, aided by a shift to impression-based (CPM) pricing. Hao asserts Weibo's strategic value \"remains solid\" in the face of stiff competition, given the \"scarcity of sizable mobile-popular marketing platforms in China,\" but also expects a spending ramp to once more pressure near-term margins.</li>\n<li>Sina mentioned on its CC (<a href=\"https://seekingalpha.com/article/2044993-sina-corporations-ceo-discusses-q4-2013-results-earnings-call-transcript\" target=\"_blank\">transcript</a>) Weibo's daily active users rose 4% Q/Q and 36% Y/Y to 61.4M, after adjusting for a methodology change. Average time spent per Weibo DAU rose 3% Q/Q and 16% Y/Y, with mobile engagement growing and PC engagement slipping.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1591453\" data-linked=\"Sina falls hard post-earnings. Weibo ad sales in focus.\" data-tweet=\"$SINA $WB - Sina falls hard post-earnings. Weibo ad sales in focus. https://seekingalpha.com/news/1591453-sina-falls-hard-post-earnings-weibo-ad-sales-in-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/1591453-sina-falls-hard-post-earnings-weibo-ad-sales-in-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591443\" data-ts=\"1393368068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591443-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hour Gainers / Losers</a></h4><ul><li><b>Top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/ZAGG' title='ZAGG Inc'>ZAGG</a> <font color='green'>+13.2%</font>. <a href='https://seekingalpha.com/symbol/EXAM' title='ExamWorks Group, Inc.'>EXAM</a> <font color='green'>+7.8%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+7.3%</font>. <a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='green'>+6.8%</font>. <a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a> <font color='green'>+6.6%</font>.</li><li><b>Top losers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a> <font color='red'>-13.2%</font>. <a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='red'>-10.9%</font>. <a href='https://seekingalpha.com/symbol/CERS' title='Cerus Corporation'>CERS</a> <font color='red'>-10.1%</font>. <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='red'>-10.0%</font>. <a href='https://seekingalpha.com/symbol/DWA' title='Dreamworks Animation SKG Inc'>DWA</a> <font color='red'>-7.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1591443\" data-linked=\"After Hour Gainers / Losers\" data-tweet=\"$ZAGG $EXAM $INO - After Hour Gainers / Losers https://seekingalpha.com/news/1591443-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1591443-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591063\" data-ts=\"1393365294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIK\" target=\"_blank\">ANIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591063-anika-resumes-trading-shares-plus-14_7-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anika resumes trading, shares +14.7% AH</a></h4><ul>\n<li>Anika (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ANIK\" title=\"Anika Therapeutics Inc.\">ANIK</a>) has made new 52-week highs AH following news <a href=\"https://seekingalpha.com/news/1590553-anikas-monovisc-approved-by-fda\" target=\"_blank\">the FDA has approved</a> its Monovisc osteoarthritis drug.</li>\n<li>The drug will be marketed in the U.S. by orthopedic sports medicine firm Mitek Sports Medicine. Anika will receive a $5M milestone payment once sales commence, and potentially additional milestone payments down the road.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1591063\" data-linked=\"Anika resumes trading, shares +14.7% AH\" data-tweet=\"$ANIK - Anika resumes trading, shares +14.7% AH https://seekingalpha.com/news/1591063-anika-resumes-trading-shares-plus-14_7-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1591063-anika-resumes-trading-shares-plus-14_7-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1591033\" data-ts=\"1393365048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAC\" target=\"_blank\">SEAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1591033-seachange-issues-fq4-warning-shares-minus-13_2-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaChange issues FQ4 warning, shares -13.2% AH</a></h4><ul>\n<li>SeaChange (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SEAC\" title=\"SeaChange International, Inc.\">SEAC</a>) expects to report FQ4 (Jan. quarter) revenue of $34.5M-$35.5M and non-GAAP op. income of $0.01-$0.02/share, below prior guidance of $40M-$45M and $0.15-$0.20/share. The consensus is for revenue of $43.5M and EPS of $0.19.</li>\n<li>The cable infrastructure hardware/software vendor blames delayed orders from Americas customers and \"continued delays in receiving some final acceptances.\"</li>\n<li>SeaChange also says it now expects FY15 (ends Jan. '15) revenue to be flat to down; the consensus is for 9% growth. The company still expects profits to grow thanks to cost cuts and stronger sales of new (higher-margin) products.</li>\n<li>\n<a href=\"http://www.schange.com/IR\" target=\"_blank\">CC</a> at 5PM ET.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1591033\" data-linked=\"SeaChange issues FQ4 warning, shares -13.2% AH\" data-tweet=\"$SEAC - SeaChange issues FQ4 warning, shares -13.2% AH https://seekingalpha.com/news/1591033-seachange-issues-fq4-warning-shares-minus-13_2-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1591033-seachange-issues-fq4-warning-shares-minus-13_2-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590953\" data-ts=\"1393364448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590953-margins-shoot-higher-at-annaly-plus-1_8-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margins shoot higher at Annaly; +1.8% AH</a></h4><ul>\n<li>Core earnings of $0.35 per share compares to $0.28 for Q3, $0.32 a year ago, and the most recent dividend of $0.30. End of year book value per share of $12.13 is down from $12.70 in Q3 and $15.85 a year ago. Today's close of $10.87 is a 10.4% discount to Dec. 31 book (which is almost certainly higher today than it was on Dec. 31).</li>\n<li>Interest rate spread of 1.43% is up a whopping 36 basis points from Q3 and 49 bps from a year ago. Better yield on investments was driven by lower prepayment speeds: CPR of 7% vs. 13% in Q3, 20% a year ago. Funding costs of 2.33% rose 31 bps from Q3, rose 80 bps from a year ago.</li>\n<li>Company continues to diversify away from fixed 30-year agency MBS paper, with commercial assets now accounting for 14% of stockholder equity. Agency MBS portfolio of $73.4B vs. $83B in Q3, $127B a year ago.</li>\n<li>Leverage of 5.0:1 compares to 5.4:1 in Q3, 6.5:1 a year ago.</li>\n<li>\n<a href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.annaly.com&amp;esheet=50811705&amp;newsitemid=20140225007054&amp;lan=en-US&amp;anchor=www.annaly.com&amp;index=1&amp;md5=310a3f99fe7964fea961c8b746d12f69\" target=\"_blank\">CC</a> tomorrow at 10 ET</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"green\">+1.8%</font> AH</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590953\" data-linked=\"Margins shoot higher at Annaly; +1.8% AH\" data-tweet=\"$NLY - Margins shoot higher at Annaly; +1.8% AH https://seekingalpha.com/news/1590953-margins-shoot-higher-at-annaly-plus-1_8-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1590953-margins-shoot-higher-at-annaly-plus-1_8-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590863\" data-ts=\"1393364018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAZZ\" target=\"_blank\">JAZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590863-jazz-minus-8-percent-ah-cfo-resigns-2014-sales-guidance-above-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jazz -8% AH. CFO resigns. 2014 sales guidance above consensus.</a></h4><ul>\n<li>Along with its Q4 results, Jazz Pharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a>) announces CFO Kathryn Falberg is resigning, effective March 9, to \"pursue other interests.\" Corporate development SVP Matthew Young is replacing Falberg.</li>\n<li>Jazz expects 2014 revenue of $1.1B-$1.16B and EPS of $8-$8.25 vs. a consensus of $1.08B and $8.07. Xyrem net sales are expected to total $755M-775M, and Erwinaze/Erwinase net sales $185M-$200M.</li>\n<li>Xyrem net sales +45% Y/Y in Q4 to $164.2M, Erwinaze/Erwinase net sales +26% to $43.5M. Opex +25% to $75.5M.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1590563-jazz-pharmaceuticals-inc-beats-by-0_07-beats-on-revenue\" target=\"_blank\">Q4 results</a>, PR.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590863\" data-linked=\"Jazz -8% AH. CFO resigns. 2014 sales guidance above consensus.\" data-tweet=\"$JAZZ - Jazz -8% AH. CFO resigns. 2014 sales guidance above consensus. https://seekingalpha.com/news/1590863-jazz-minus-8-percent-ah-cfo-resigns-2014-sales-guidance-above-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/1590863-jazz-minus-8-percent-ah-cfo-resigns-2014-sales-guidance-above-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590773\" data-ts=\"1393363735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590773-questcor-slips-after-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Questcor slips after results</a></h4><ul>\n<li>8.1K vials of Acthar shipped during quarter vs. 6.33K one year ago. For the full year, shipments of 28.1K vs. 20.7K in 2012.</li>\n<li>New paid prescriptions for Acthar of about 2.45K-2.5K up about 30% Y/Y. Rheumatology prescriptions now account for nearly 30% of Acthar business. In January, company began with a small pilot sales force to educate pulmonologists about Acthar in the treatment of respiratory manifestations of orphan disease symptomatic sarcoidosis.</li>\n<li>960K shares repurchased during Q for average price of $55.26 each, a total of $53.1M. About 5.3M shares remain under existing authorization. End-of-year float of 62.3M shares.</li>\n<li>\"Management is working closely with the Board's newly formed Strategic Advisory Committee to support the Company's investigation and evaluation of potential strategies to use its future potential cash flow to generate long-term growth and value for shareholders.\"</li>\n<li>\n<a href=\"http://ir.questcor.com/\" target=\"_blank\">CC</a> at 4:30 ET</li>\n<li>QCOR <font color=\"red\">-3.4%</font> AH</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590773\" data-linked=\"Questcor slips after results\" data-tweet=\"$MNK - Questcor slips after results https://seekingalpha.com/news/1590773-questcor-slips-after-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1590773-questcor-slips-after-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590723\" data-ts=\"1393363315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590723-first-solars-guidance-disappoints-shares-minus-10_2-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar&#39;s guidance disappoints, shares -10.2% AH</a></h4><ul>\n<li>In addition to missing Q4 estimates, First Solar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a>) is guiding for Q1 revenue of $800M-$900M and EPS of $0.50-$0.60, largely below a consensus of $898.3M and $0.84.</li>\n<li>443.7MW of solar modules were produced, +4% Q/Q and -13% Y/Y. Conversion efficiency +10 bps Q/Q and +50 bps Y/Y to 13.4%, cost/watt fell by $0.03 Q/Q and $0.12 Y/Y to $0.56.</li>\n<li>Gross margin -420 bps Q/Q and -270 bps Y/Y to 24.6%. SG&amp;A spend +4% Y/Y to $65.7M, R&amp;D +22% to $38.4M. Free cash flow was $137M, down from $284M in Q3 and $253M a year ago.</li>\n<li>Expected future module shipments were at 2.7GW at the end of Q4, flat Q/Q and up 100MW Y/Y. Expected future systems/module revenue was at $7.5B, down $300M Q/Q and $500M Y/Y. But potential opportunities rose to 10.6GW from 7.7GW.</li>\n<li>\n<a href=\"http://www.media-server.com/m/p/9q9uy4hy\" target=\"_blank\">CC</a> at 4:30PM ET. <a href=\"https://seekingalpha.com/news/1590533-first-solar-inc-misses-by-0_10-misses-on-revenue\" target=\"_blank\">Q4 results</a>, PR, <a href=\"http://investor.firstsolar.com/common/download/download.cfm?companyid=FSLR&amp;fileid=728650&amp;filekey=1dd639dd-ea51-466d-9d4a-772a4d8d4880&amp;filename=Q4_2013_Web_Schedule_vfinal.pdf\" target=\"_blank\">datasheet</a>, <a href=\"http://investor.firstsolar.com/common/download/download.cfm?companyid=FSLR&amp;fileid=728649&amp;filekey=bddfd430-a025-43e4-8b91-c1915066b274&amp;filename=Q413_Earnings_Call_Presentation_Final1.pdf\" target=\"_blank\">slides</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590723\" data-linked=\"First Solar&#39;s guidance disappoints, shares -10.2% AH\" data-tweet=\"$FSLR - First Solar&#39;s guidance disappoints, shares -10.2% AH https://seekingalpha.com/news/1590723-first-solars-guidance-disappoints-shares-minus-10_2-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1590723-first-solars-guidance-disappoints-shares-minus-10_2-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590623\" data-ts=\"1393362804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWA\" target=\"_blank\">DWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590623-disappointing-quarter-from-dreamworks-animation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disappointing quarter from DreamWorks Animation</a></h4><ul> <li>DreamWorks Animation (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DWA\" title=\"Dreamworks Animation SKG Inc\">DWA</a>) misses the Q4 profit estimate of analysts on SG&amp;A expenses which came in higher than forecast.</li> <li>The feature film segment contributed revenue of $128M, while the Television segment kicked in $47M.</li> <li>DWA <font color=\"red\">-6.3%</font> AH to give up the gains racked over the last week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1590623\" data-linked=\"Disappointing quarter from DreamWorks Animation\" data-tweet=\"$DWA - Disappointing quarter from DreamWorks Animation https://seekingalpha.com/news/1590623-disappointing-quarter-from-dreamworks-animation?source=tweet\" data-url=\"https://seekingalpha.com/news/1590623-disappointing-quarter-from-dreamworks-animation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590443\" data-ts=\"1393362086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMT\" target=\"_blank\">AMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590443-american-tower-slides-following-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Tower slides following earnings, guidance</a></h4><ul>\n<li>Thanks partly to <a href=\"https://seekingalpha.com/news/1264442-american-tower-buys-global-tower-partners-parent-company\" target=\"_blank\">acquisitions</a>, American Tower (<a href=\"https://seekingalpha.com/symbol/AMT\" title=\"American Tower Corporation\">AMT</a> <font color=\"red\">-3.4%</font>) expects its 2014 rental/management revenue of $3.82B-$3.91B, up from a 2013 level of $3.29B. AFFO is expected to grow to $1.68B-$1.74B from 2013's $1.47B, and capex is expected to be in a range of $850M-$950M.</li>\n<li>While total revenue rose 22.6% Y/Y in Q4, organic core revenue rose 11.2% - 8.7% domestic, 13.5% international. Total domestic revenue +24.6% Y/Y to $622.7M, total international revenue +25.6% to $301.2M.</li>\n<li>Op. margin was flat Y/Y at 68%. AMT ended 2013 with 67K+ sites, and expects to construct 2,250-2,750 new sites in 2014.</li>\n<li>The company ended the year with $14.5B in debt, and $294M in cash/equivalents.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1588583-american-tower-corporation-beats-on-revenue\" target=\"_blank\">Q4 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590443\" data-linked=\"American Tower slides following earnings, guidance\" data-tweet=\"$AMT - American Tower slides following earnings, guidance https://seekingalpha.com/news/1590443-american-tower-slides-following-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1590443-american-tower-slides-following-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590393\" data-ts=\"1393361148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JONE\" target=\"_blank\">JONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590393-jones-energy-minus-15-percent-despite-30-percent-2014-production-growth-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jones Energy -15% despite 30% 2014 production growth guidance</a></h4><ul>     <li>Jones Energy (<a href=\"https://seekingalpha.com/symbol/JONE\" title=\"Jones Energy, Inc.\">OTC:JONE</a> <font color=\"red\">-15.3%</font>) is one of the day's largest NYSE decliners after providing an operations update and 2014 guidance.</li>     <li>Q4 production rose to a record 1.7M boe (~18.2K boe/day)  despite severe weather; FY 2013 production of 6.2M boe (~17K boe/day) was within the previously  announced guidance range.</li>     <li>Says 2013 year-end proved reserves rose 23% Y/Y, and increased 42% in the core Cleveland area; oil and natural gas liquids rose to 56% of the proved reserve base.</li>     <li>Projecting 2014 average daily production of 22K-23K boe/day, which would mean ~30% Y/Y production growth; plans ~$350M capex for the year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1590393\" data-linked=\"Jones Energy -15% despite 30% 2014 production growth guidance\" data-tweet=\"$JONE - Jones Energy -15% despite 30% 2014 production growth guidance https://seekingalpha.com/news/1590393-jones-energy-minus-15-percent-despite-30-percent-2014-production-growth-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1590393-jones-energy-minus-15-percent-despite-30-percent-2014-production-growth-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590343\" data-ts=\"1393359652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590343-get-set-to-buy-us-steel-steel-dynamics-morgan-stanley-suggests\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Get set to buy US Steel, Steel Dynamics, Morgan Stanley suggests</a></h4><ul>     <li>Shares of US Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"red\">-2.4%</font>) have slipped 20% YTD while Steel Dynamics (<a href=\"https://seekingalpha.com/symbol/STLD\" title=\"Steel Dynamics, Inc.\">STLD</a> <font color=\"red\">-0.8%</font>) has dropped 13.5%, prompting Morgan Stanley\u2019s Evan Kurtz to say it might be <a href=\"http://blogs.barrons.com/stockstowatchtoday/2014/02/25/morgan-stanley-buy-us-steel-on-weakness-steel-dynamics-a-bargain\" target=\"_blank\">time to buy</a> shares even amid weakening steel prices.</li>     <li>On US Steel, the firm believes the company specific EBITDA tailwinds described by management on the last earnings call are too compelling to ignore, and sees any price cycle related weakness as a buying opportunity.</li>     <li>STLD is a bargain at current levels, the firm says - a top notch operator that trades below fair value, and it is pursuing two major projects that are ramping up this year and will add to mid-cycle earnings power.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1590343\" data-linked=\"Get set to buy US Steel, Steel Dynamics, Morgan Stanley suggests\" data-tweet=\"$X $X $STLD - Get set to buy US Steel, Steel Dynamics, Morgan Stanley suggests https://seekingalpha.com/news/1590343-get-set-to-buy-us-steel-steel-dynamics-morgan-stanley-suggests?source=tweet\" data-url=\"https://seekingalpha.com/news/1590343-get-set-to-buy-us-steel-steel-dynamics-morgan-stanley-suggests\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590323\" data-ts=\"1393358881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOMA\" target=\"_blank\">XOMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590323-xoma-plus-4-percent-as-gevokizumab-wins-fda-orphan-drug-status\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XOMA +4% as gevokizumab wins FDA orphan drug status</a></h4><ul>     <li>XOMA Corp. (<a href=\"https://seekingalpha.com/symbol/XOMA\" title=\"XOMA Corporation\">XOMA</a> <font color=\"green\">+4%</font>) hits a new 52-week high after confirming late yesterday that the FDA granted orphan drug status for its gevokizumab antibody as a treatment for the treatment of pyoderma gangrenosum, a condition which causes skin tissue to develop deep uclers.</li>\n<li>Gevokizumab is now in Phase III testing to measure its ability to treat acute, non-infectious inflammation of the iris and other vascular structures of the eye in patients with Behcet's uvelitis.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590323\" data-linked=\"XOMA +4% as gevokizumab wins FDA orphan drug status\" data-tweet=\"$XOMA - XOMA +4% as gevokizumab wins FDA orphan drug status https://seekingalpha.com/news/1590323-xoma-plus-4-percent-as-gevokizumab-wins-fda-orphan-drug-status?source=tweet\" data-url=\"https://seekingalpha.com/news/1590323-xoma-plus-4-percent-as-gevokizumab-wins-fda-orphan-drug-status\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590303\" data-ts=\"1393358327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAAS\" target=\"_blank\">PAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590303-pan-am-silver-cut-to-sell-at-goldman-as-silver-prices-seen-overvalued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pan Am Silver cut to Sell at Goldman as silver prices seen overvalued</a></h4><ul>     <li>Pan American Silver (<a href=\"https://seekingalpha.com/symbol/PAAS\" title=\"Pan American Silver Corp.\">PAAS</a> <font color=\"red\">-1.9%</font>) is <a href=\"http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Pan+Am+Silver+%28PAAS%29+to+Sell+on+Weak+Silver+Prices/9210809.html\" target=\"_blank\">downgraded to Sell</a> from Neutral with a $10 price target at Goldman Sachs, which forecasts silver at $21.80/oz. from 2015 onwards, driven by a lack of supply-side response.</li>\n<li>While PAAS has a strong balance sheet, the revised silver price  deck suggests the company's ability to generate free cash flow is  limited, the firm says.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/SLV\" title=\"iShares Silver Trust ETF\">SLV</a>, <a href=\"https://seekingalpha.com/symbol/AGQ\" title=\"ProShares Ultra Silver ETF\">AGQ</a>, <a href=\"https://seekingalpha.com/symbol/SIVR\" title=\"Aberd Std Silvr Shs\">SIVR</a>, <a href=\"https://seekingalpha.com/symbol/USLV\" title=\"VelocityShares 3x Long Silver ETN\">USLV</a>, <a href=\"https://seekingalpha.com/symbol/ZSL\" title=\"ProShares UltraShort Silver ETF\">ZSL</a>, <a href=\"https://seekingalpha.com/symbol/DSLV\" title=\"VelocityShares 3x Inverse Silver ETN\">DSLV</a>, <a href=\"https://seekingalpha.com/symbol/DBS\" title=\"Invesco DB Silver ETF\">DBS</a>, <a href=\"https://seekingalpha.com/symbol/SLVO\" title=\"Credit Suisse Silver Shares Covered Call ETN\">SLVO</a>, <a href=\"https://seekingalpha.com/symbol/USV\" title=\"UBS ETRACS CMCI Silver Total Return ETN\">USV</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590303\" data-linked=\"Pan Am Silver cut to Sell at Goldman as silver prices seen overvalued\" data-tweet=\"$PAAS $PAAS $SLV - Pan Am Silver cut to Sell at Goldman as silver prices seen overvalued https://seekingalpha.com/news/1590303-pan-am-silver-cut-to-sell-at-goldman-as-silver-prices-seen-overvalued?source=tweet\" data-url=\"https://seekingalpha.com/news/1590303-pan-am-silver-cut-to-sell-at-goldman-as-silver-prices-seen-overvalued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590293\" data-ts=\"1393357803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590293-fireeye-jumps-after-launching-managed-security-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FireEye jumps after launching managed security service</a></h4><ul>\n<li>Managed Defense, a subscription service that complements FireEye's (<a href=\"https://seekingalpha.com/symbol/FEYE\" title=\"FireEye, Inc.\">FEYE</a> <font color=\"green\">+7.7%</font>) threat-prevention hardware and software, relies on FireEye analysts to provide monitoring and incident response services for <a href=\"http://en.wikipedia.org/wiki/Advanced_persistent_threat\" target=\"_blank\">APT</a> and <a href=\"http://en.wikipedia.org/wiki/Zero-day_attack\" target=\"_blank\">zero-day</a> attacks.</li>\n<li>The service launch comes on the heels of FireEye's <a href=\"https://seekingalpha.com/news/1489651-fireeye-acquiring-endpoint-security-firm-ups-guidance\" target=\"_blank\">acquisition</a> of endpoint security upstart Mandiant, which <a href=\"https://www.mandiant.com/services/\" target=\"_blank\">already offers</a> incident response and threat-assessment services.</li>\n<li>Leveraging Mandiant's products, FireEye launched a new endpoint threat detection/response solution earlier this month - it features both a security appliance and endpoint software.</li>\n<li>FireEye's product subscription billings totaled $38.7M in Q4, or 40% of total billings.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590293\" data-linked=\"FireEye jumps after launching managed security service\" data-tweet=\"$FEYE - FireEye jumps after launching managed security service https://seekingalpha.com/news/1590293-fireeye-jumps-after-launching-managed-security-service?source=tweet\" data-url=\"https://seekingalpha.com/news/1590293-fireeye-jumps-after-launching-managed-security-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590273\" data-ts=\"1393357134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590273-rosetta-resources-minus-8-percent-as-q4-brings-no-new-meaningful-well-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Resources -8% as Q4 brings no new meaningful well results</a></h4><ul>     <li>Rosetta Resources (<a href=\"https://seekingalpha.com/symbol/ROSE\" title=\"Rosehill Resources Inc.\">ROSE</a> <font color=\"red\">-8.1%</font>) sinks after reporting <a href=\"https://seekingalpha.com/news/1587913-rosetta-resources-beats-by-0_05-misses-on-revenues\" target=\"_blank\">mixed Q4 results</a> with minimal new data and no new meaningful well results; earnings beat analyst estimates and revenue fell short.</li>     <li>ROSE also reaffirmed its planned $1.1B capital spending level and FY 2014 production guidance of 60M-65M boe/day.</li>     <li>Howard Weil <a href=\"http://www.streetinsider.com/Downgrades/Howard+Weil+Downgrades+Rosetta+Resources+%28ROSE%29+to+Outperform/9211818.html\" target=\"_blank\">downgrades</a> shares to Sector Outperform from Focus Stock and lowers its price target to $65 from $72; the Delaware Basin asset should be the next value driver for ROSE, and the firm says it continues to be surprised that the acreage is not getting more credit in today's stock action and does not know what will make it be better understood besides more operated wells.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1590273\" data-linked=\"Rosetta Resources -8% as Q4 brings no new meaningful well results\" data-tweet=\"$NBL - Rosetta Resources -8% as Q4 brings no new meaningful well results https://seekingalpha.com/news/1590273-rosetta-resources-minus-8-percent-as-q4-brings-no-new-meaningful-well-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1590273-rosetta-resources-minus-8-percent-as-q4-brings-no-new-meaningful-well-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590253\" data-ts=\"1393356207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590253-t-mobile-usa-sells-off-following-q4-report-2014-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile USA sells off following Q4 report, 2014 guidance</a></h4><ul>\n<li>After opening near breakeven following its Q4 report, T-Mobile USA (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"red\">-6.1%</font>) has gradually sold off.</li>\n<li>The #4 U.S. carrier, which halted years of postpaid sub losses last year with the help of the iPhone and aggressive/novel subscription plans, expects to add 2M-3M branded postpaid subs in 2014, compared with 2M in 2013. Cash capex is expected to grow to $4.3B-$4.6B from 2013's $4.2B, and adjusted EBITDA (-17% Y/Y in 2013) to $5.7B-$6B from 2013's $5.3B.</li>\n<li>As <a href=\"https://seekingalpha.com/news/1498581-t-mobile-offers-up-to-650-in-credit-to-switching-users-provides-q4-numbers\" target=\"_blank\">announced on Jan. 8</a>, T-Mobile added 1.645M total subs, 869K branded postpaid subs, and 112K branded prepaid subs in Q4.</li>\n<li>\"Simple free cash flow\" (adjusted EBITDA - cash capex) rose 79% Y/Y to $357M, and totaled $1.08B for the whole of 2013 (-59% Y/Y). ARPU fell 2.9% Q/Q to $50.70.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1588403-t-mobile-us-inc-beats-by-0_11-misses-on-revenue\" target=\"_blank\">Q4 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590253\" data-linked=\"T-Mobile USA sells off following Q4 report, 2014 guidance\" data-tweet=\"$TMUS - T-Mobile USA sells off following Q4 report, 2014 guidance https://seekingalpha.com/news/1590253-t-mobile-usa-sells-off-following-q4-report-2014-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1590253-t-mobile-usa-sells-off-following-q4-report-2014-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590243\" data-ts=\"1393355643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITMN\" target=\"_blank\">ITMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590243-intermune-now-an-ideal-acquisition-target-baird-says-in-raising-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterMune now an ideal acquisition target, Baird says in raising price target</a></h4><ul>     <li>InterMune's (<a href=\"https://seekingalpha.com/symbol/ITMN\" title=\"InterMune, Inc.\">ITMN</a> <font color=\"green\">+162.8%</font>) spectacular gains after reporting positive ASCEND data (<a href=\"https://seekingalpha.com/news/1588823-intermunes-pirfenidone-meets-phase-iii-trial-goals\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/news/1589883-pirfenidone-results-look-great-says-summer-street\" target=\"_blank\">II</a>) may have further to go, Baird analyst Brian Skorney believes, viewing ITMN as an <a href=\"http://www.streetinsider.com/Analyst+Comments/InterMune+%28ITMN%29+Target+Lifted+to+%2444+at+Baird%3B+Now+Makes+Ideal+Acquisition+Target/9213469.html\" target=\"_blank\">ideal acquisition target</a> for a big pharma company.</li>     <li>A substantial unmet need in idiopathic pulmonary fibrosis provides a  blockbuster market opportunity, Baird says, with a number of companies with  the capability to sell ITMN's drug with their current salesforce, most  notably GlaxoSmithKline (NYSE:<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>), Gilead (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) and Novartis (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>); Skorney sees a potential acquisition price into the 60s.</li>     <li>Even without an acquisition, Skorney thinks ITMN should reach $44, with clinical risk is now in the rear-view  mirror and potential for greater penetration and higher pricing  in the U.S.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1590243\" data-linked=\"InterMune now an ideal acquisition target, Baird says in raising price target\" data-tweet=\"$ITMN $ITMN $GSK - InterMune now an ideal acquisition target, Baird says in raising price target https://seekingalpha.com/news/1590243-intermune-now-an-ideal-acquisition-target-baird-says-in-raising-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/1590243-intermune-now-an-ideal-acquisition-target-baird-says-in-raising-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590193\" data-ts=\"1393353543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590193-frontier-flies-higher-as-street-cheers-subscriber-margin-imporvement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier flies higher as Street cheers subscriber, margin imporvement</a></h4><ul>\n<li>Range-bound for much of 2013, Frontier (<a href=\"https://seekingalpha.com/symbol/FTR\" title=\"Frontier Communications Corporation\">FTR</a> <font color=\"green\">+9%</font>) has soared to new 52-week highs after providing better-than-expected <a href=\"https://seekingalpha.com/news/1587853-frontier-plus-2_6-percent-ah-residential-sub-losses-narrow-in-q4\" target=\"_blank\">subscriber and margin figures</a> in its Q4 report.</li>\n<li>\n<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/14/02/4341420/morgan-stanley-sees-continued-broadband-momentum-as-posi\" target=\"_blank\">Morgan Stanley</a> (Equal-Weight) notes Frontier's Q4 EBITDA ($570M) beat consensus by $21M thanks in part to cost cuts, and that the telco's 27.8K broadband net adds came in the face of tougher cable competition.</li>\n<li>On the CC (<a href=\"https://seekingalpha.com/article/2044653-frontier-communications-ceo-discusses-q4-2013-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), Frontier asserted it gained residential broadband share in 79% of its markets in Q4, and estimates its aggregate share is still in the low-20% range. The company also mentioned over 40% of the Connecticut AT&amp;T territory it's <a href=\"https://seekingalpha.com/news/1468161-frontier-communications-lands-at-and-ts-connecticut-wireline-business\" target=\"_blank\">set to acquire</a> is covered by U-verse.</li>\n<li>Frontier's dividend yield currently stands at 7.99%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590193\" data-linked=\"Frontier flies higher as Street cheers subscriber, margin imporvement\" data-tweet=\"$FTR - Frontier flies higher as Street cheers subscriber, margin imporvement https://seekingalpha.com/news/1590193-frontier-flies-higher-as-street-cheers-subscriber-margin-imporvement?source=tweet\" data-url=\"https://seekingalpha.com/news/1590193-frontier-flies-higher-as-street-cheers-subscriber-margin-imporvement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590153\" data-ts=\"1393352088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARE\" target=\"_blank\">RARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590153-buys-across-the-board-as-coverage-launched-on-ultragenyx-and-cara\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buys across the board as coverage launched on Ultragenyx and Cara</a></h4><ul>\n<li>\"Ultragenyx (<a href=\"https://seekingalpha.com/symbol/RARE\" title=\"Ultragenyx Pharmaceutical Inc.\">RARE</a> <font color=\"green\">+3.8%</font>) has a broad and promising pipeline consisting of four therapies for five rare and serious genetic diseases,\" says Canaccord analyst Salveen Richter, initiating the red-hot recently IPOd stock <a href=\"http://www.streetinsider.com/New+Coverage/UPDATE%3A+Canaccord+Genuity+Starts+Cara+Therapeutics+%28CARA%29+at+Buy/9211035.html\" target=\"_blank\">with a Buy and $85 price target</a>. \"We like the orphan-disease-focused strategy for early proof-of-concept, short time-to-clinic, exclusivity and pricing power and particularly the leveragability of this model.\" He estimates $1B in peak worldwide sales for the company, with high chance of securing regulatory approval. \" In addition, we view the preclinical asset (rhPPCA) as a free call option and expect a continued focus on early-stage R&amp;D.\"</li>\n<li>Cowen and Morgan also launch coverage with Buys.</li>\n<li>Ahead since its IPO, but a relative slacker compared to RARE, Cara Therapeutics (<a href=\"https://seekingalpha.com/symbol/CARA\" title=\"Cara Therapeutics Inc.\">CARA</a> <font color=\"green\">+2.6%</font>) also <a href=\"http://www.streetinsider.com/New+Coverage/UPDATE%3A+Canaccord+Genuity+Starts+Cara+Therapeutics+%28CARA%29+at+Buy/9211035.html\" target=\"_blank\">rates a Buy from Canaccord</a> with $25 price target. \"We expect positive data from three upcoming post-op Ph3 studies in H2/15,\" says analyst Ritu Baral. \"We think \u2018845 could gain significant market share and model potential US peak sales of $750M.\"</li>\n<li>Stifel, Janney, and Piper also chime in with Buy ratings.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590153\" data-linked=\"Buys across the board as coverage launched on Ultragenyx and Cara\" data-tweet=\"$RARE $RARE $CARA - Buys across the board as coverage launched on Ultragenyx and Cara https://seekingalpha.com/news/1590153-buys-across-the-board-as-coverage-launched-on-ultragenyx-and-cara?source=tweet\" data-url=\"https://seekingalpha.com/news/1590153-buys-across-the-board-as-coverage-launched-on-ultragenyx-and-cara\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590143\" data-ts=\"1393352040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZU\" target=\"_blank\">ZU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590143-zulily-blasts-off-on-q4-beat-guidance-groupon-also-jumps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zulily blasts off on Q4 beat, guidance. Groupon also jumps.</a></h4><ul>\n<li>Zulily (<a href=\"https://seekingalpha.com/symbol/ZU\" title=\"Zulily, Inc.\">ZU</a> <font color=\"green\">+39.9%</font>) is turning in a memorable day after <a href=\"https://seekingalpha.com/news/1587593-zulily-inc-beats-by-0_06-beats-on-revenue\" target=\"_blank\">trouncing</a> Q4 estimates and issuing strong <a href=\"https://seekingalpha.com/news/1587893-zulily-plus-9-percent-ah-on-q4-beat-strong-guidance\" target=\"_blank\">Q1/2014 guidance</a>. Shares of the apparel flash sales site are now up nearly 3x from a November IPO price of $22.</li>\n<li>Daily deals leader Groupon (<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a> <font color=\"green\">+7.4%</font>), <a href=\"https://seekingalpha.com/news/1584673-two-downgrades-for-groupon-bulls-focus-on-mobile-growth-initiatives\" target=\"_blank\">clobbered</a> last week following its Q4 report, is following Zulily higher. E-commerce marketing services providers RetailMeNot (<a href=\"https://seekingalpha.com/symbol/SALE\" title=\"RetailMeNot, Inc.\">SALE</a> <font color=\"green\">+2.2%</font>) and ChannelAdvisor (<a href=\"https://seekingalpha.com/symbol/ECOM\" title=\"ChannelAdvisor Corp\">ECOM</a> <font color=\"green\">+2.5%</font>) are also posting decent gains.</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Zulily+%28ZU%29+Target+Lifted+to+%2450+at+RBC+Capital/9210782.html\" target=\"_blank\">RBC</a> (Outperform) has hiked its Zulily PT to $50 from $40 - if shares hold onto their gains, another hike will be needed for RBC to keep its rating. The firm is happy with Zulily's 568K Q4 active customer adds and 6.9% EBITDA margin (+320 bps Y/Y due to marketing/SG&amp;A leverage), though it also notes gross margin (26.6%) was slightly below a 27.4% consensus.</li>\n<li>Zulily mentioned on its CC (<a href=\"https://seekingalpha.com/article/2044733-zulilys-ceo-discusses-q4-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>) 45% of its Q4 North American orders came via mobile devices, up from 31% a year ago. The company also spent considerable time talking up its efforts to diversify - it now supports 300 merchants, and offers over 4.5K new products each day.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590143\" data-linked=\"Zulily blasts off on Q4 beat, guidance. Groupon also jumps.\" data-tweet=\"$ZU $ZU $GRPN - Zulily blasts off on Q4 beat, guidance. Groupon also jumps. https://seekingalpha.com/news/1590143-zulily-blasts-off-on-q4-beat-guidance-groupon-also-jumps?source=tweet\" data-url=\"https://seekingalpha.com/news/1590143-zulily-blasts-off-on-q4-beat-guidance-groupon-also-jumps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590103\" data-ts=\"1393350541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVBD\" target=\"_blank\">RVBD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590103-elliott-ups-riverbed-offer-to-21-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott ups Riverbed offer to $21/share</a></h4><ul>\n<li>Elliott Management has hiked its buyout offer for Riverbed (<a href=\"https://seekingalpha.com/symbol/RVBD\" title=\"Riverbed Technology, Inc.\">RVBD</a> <font color=\"green\">+4.4%</font>) by $2/share to $21/share. Riverbed, which closed yesterday at $19.85, spiked as high as $21.19 in response to the offer, but has quickly pared its gains.</li>\n<li>Elliott, which made its <a href=\"https://seekingalpha.com/news/1497761-elliott-management-offers-to-buy-riverbed-for-19-share\" target=\"_blank\">original offer</a> on Jan. 8 (it was <a href=\"https://seekingalpha.com/news/1508461-riverbed-rejects-elliots-offer-sees-strong-q4\" target=\"_blank\">rejected</a> on Jan. 15), says talks with Riverbed have \"yielded no indication that the Company understands the potential for a sale process to create a value-maximizing outcome.\"</li>\n<li>The firm also takes aim at Riverbed's top-line performance (Q1 revenue is expected to grow 5% Y/Y at Riverbed's guidance midpoint), \"excessive\" opex, and \"unrealistic\" plan to achieve consistent 10% rev. growth.</li>\n<li>With only three Riverbed directors up for election this year (one of whom is likely to leave), Elliott says it didn't nominate any directors prior to a Sunday deadline, and asserts \"the change that is needed at Riverbed cannot be best effectuated through alternative nominations at this time.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1590103\" data-linked=\"Elliott ups Riverbed offer to $21/share\" data-tweet=\"$RVBD - Elliott ups Riverbed offer to $21/share https://seekingalpha.com/news/1590103-elliott-ups-riverbed-offer-to-21-share?source=tweet\" data-url=\"https://seekingalpha.com/news/1590103-elliott-ups-riverbed-offer-to-21-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590093\" data-ts=\"1393350403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590093-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Top 10 Gainers:</b> <a href='https://seekingalpha.com/symbol/ITMN' title='InterMune, Inc.'>ITMN</a> <font color='green'>+156%</font>. <a href='https://seekingalpha.com/symbol/ZU' title='Zulily, Inc.'>ZU</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a> <font color='green'>+37%</font>. DARA <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+17%</font>.</li><li><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/RP' title='RealPage'>RP</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/EVRY' title='EveryWare Global, Inc.'>EVRY</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/PERY' title='Perry Ellis International Inc.'>PERY</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CCCL' title='China Ceramics Co., Ltd.'>CCCL</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/RBPAA' title='Royal Bancshares of Pennsylvania, Inc.'>RBPAA</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LMOS' title='Lumos Networks Corp.'>LMOS</a> <font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1590093\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ITMN $ZU $HPJ - Midday Gainers / Losers https://seekingalpha.com/news/1590093-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1590093-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590083\" data-ts=\"1393350274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590083-morgan-stanley-teslas-business-model-is-bigger-than-you-think\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley: Tesla&#39;s business model is bigger than you think</a></h4><ul>     <li>It's all green lights for Tesla Motors (<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a> <font color=\"green\">+17.1%</font>) with the Model S and Model X set to create a \"100% captive ecosystem\" for the company, according to Morgan Stanley.</li>     <li>Analyst Adam Jonas <a href=\"http://www.valuewalk.com/2014/02/tesla-motors-inc-tsla-stock-high-on-morgan-stanley-report/\" target=\"_blank\">sees</a> Tesla Motors grabbing a respectable 0.9% of the global automobile market by 2028, but it's in other industries the analyst gets dreamy over Tesla's profit potential.</li>     <li>By having a jump on rivals with its gigafactory, Tesla could dive right into the $1.5T electric utility market. Morgan identifies a wide variety of potential energy plays for Tesla - including off-peak grid storage, transportable energy storage systems, and black start provisions for end users.</li>     <li>Autonomous cars is another burgeoning industry in which Tesla could be well-positioned due to its early start with connected EVs. It doesn't hurt to be the only automaker with a corporate headquarters in Silicon Valley as technology with self-driving cars races forward.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1590083\" data-linked=\"Morgan Stanley: Tesla&#39;s business model is bigger than you think\" data-tweet=\"$TSLA - Morgan Stanley: Tesla&#39;s business model is bigger than you think https://seekingalpha.com/news/1590083-morgan-stanley-teslas-business-model-is-bigger-than-you-think?source=tweet\" data-url=\"https://seekingalpha.com/news/1590083-morgan-stanley-teslas-business-model-is-bigger-than-you-think\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1590043\" data-ts=\"1393349216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1590043-tenet-healthcare-minus-10_6-percent-s-and-ps-worst-as-outlook-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenet Healthcare -10.6%, S&amp;P&#39;s worst, as outlook disappoints</a></h4><ul>     <li>Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='red'>-10.6%</font>) is the S&amp;P 500's worst performer as <a href=\"https://seekingalpha.com/news/1587653-tenet-healthcare-corporation-beats-by-0_12-beats-on-revenue\" target=\"_blank\">Q4 earnings</a> beat forecasts but took on $400M in new debt and offered lower-than-expected guidance; the hospital operator sees Q1 adjusted EBITDA of $350M-$400M and FY 2014 EBITDA of $1.8B-$1.9B vs. analyst consensus estimates of $447M and $1.96B.</li>     <li>THC reported Q4 adjusted admissions fell 0.5%, as inpatient admissions fell 2.3%; operating margin narrowed to 4.3% from 9.1%, as operating expenses jumped 75%.</li><li>CRT&nbsp;Capital <a href=\"http://www.streetinsider.com/Downgrades/CRT+Capital+Downgrades+Tenet+Healthcare+%28THC%29+to+Fairly+Valued/9211770.html\" target=\"_blank\">downgrades</a> THC to Fair Value from Buy as accretion from the Vanguard Health Systems acquisition has  not materialized in the near-term; instead of generating significant  EBITDA growth, the business contracted from Q4 to Q1 and CRT's guidance  suggests that the business will continue to shrink.</li><li>On the other hand, Mizuho says it would be buyers on today's stock weakness, viewing initial 2014 EBITDA guidance as achievable given conservative  assumptions around health reform coupled with a continued soft admission  outlook (Briefing.com).</li></ul><div class=\"tiny-share-widget\" data-id=\"1590043\" data-linked=\"Tenet Healthcare -10.6%, S&amp;P&#39;s worst, as outlook disappoints\" data-tweet=\"$THC - Tenet Healthcare -10.6%, S&amp;P&#39;s worst, as outlook disappoints https://seekingalpha.com/news/1590043-tenet-healthcare-minus-10_6-percent-s-and-ps-worst-as-outlook-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/1590043-tenet-healthcare-minus-10_6-percent-s-and-ps-worst-as-outlook-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589883\" data-ts=\"1393345610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITMN\" target=\"_blank\">ITMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589883-pirfenidone-results-look-great-says-summer-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pirfenidone results &quot;look great&quot; says Summer Street</a></h4><ul>\n<li>\"We believe that the data was impressive and should lead to FDA approval as well as increased sales in the EU,\" says the<a href=\"http://www.streetinsider.com/Analyst+Comments/InterMune+%28ITMN%29+Trial+Data+Looks+Great%2C+Summer+Street+Says/9212981.html\" target=\"_blank\"> team at Summer Street</a>, commenting on the <a href=\"https://seekingalpha.com/news/1588823-intermunes-pirfenidone-meets-phase-iii-trial-goals\" target=\"_blank\">Phase III trial results</a> for InterMune's (<a href=\"https://seekingalpha.com/symbol/ITMN\" title=\"InterMune, Inc.\">ITMN</a> <font color=\"green\">+158.4%</font>) Pirfenidone.</li>\n<li>\"The trial met its primary endpoint, improved force vital capacity (p&lt;0.000001). The company reported the trial also met several endpoints including six-minute walk test distance change (p=0.0360) and progression-free survival (p=0.0001). Pooled data from the ASCEND trial and the previous two phase III CAPACITY trials showed an statistically significant improvement in mortality (HR=0.52, log rank p=0.0107).\"</li>\n<li>Oppenheimer<a href=\"http://www.streetinsider.com/Analyst+PT+Change/InterMune+%28ITMN%29+Price+Target+Raised+to+%2442+at+Oppenheimer/9212959.html\" target=\"_blank\"> boosts</a> its price target to $42 from $19.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589883\" data-linked=\"Pirfenidone results &quot;look great&quot; says Summer Street\" data-tweet=\"$ITMN - Pirfenidone results &quot;look great&quot; says Summer Street https://seekingalpha.com/news/1589883-pirfenidone-results-look-great-says-summer-street?source=tweet\" data-url=\"https://seekingalpha.com/news/1589883-pirfenidone-results-look-great-says-summer-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589873\" data-ts=\"1393344941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589873-immunocellular-plus-13_2-percent-wins-orphan-drug-status-for-ictminus-107-in-the-eu\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoCellular +13.2%, wins orphan drug status for ICT-107 in the EU</a></h4><ul>     <li>ImmunoCellular Therapeutics (<a href=\"https://seekingalpha.com/symbol/IMUC\" title=\"ImmunoCellular Therapeutics, Ltd.\">OTCPK:IMUC</a> <font color=\"green\">+13.2%</font>) says it has been granted orphan drug designation for ICT-107 for the treatment of  patients with glioblastoma.</li>     <li>Granting of orphan drug status in the EU  provides sponsor companies with incentives, including a 10-year period of market exclusivity, access to a centralized review process, trial design assistance and scientific advice during product development, fee reductions, and tax incentives.</li>     <li>IMUC already had received orphan designation for ICT-107 in glioblastoma in the U.S.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589873\" data-linked=\"ImmunoCellular +13.2%, wins orphan drug status for ICT-107 in the EU\" data-tweet=\"$IMUC - ImmunoCellular +13.2%, wins orphan drug status for ICT-107 in the EU https://seekingalpha.com/news/1589873-immunocellular-plus-13_2-percent-wins-orphan-drug-status-for-ictminus-107-in-the-eu?source=tweet\" data-url=\"https://seekingalpha.com/news/1589873-immunocellular-plus-13_2-percent-wins-orphan-drug-status-for-ictminus-107-in-the-eu\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589863\" data-ts=\"1393344853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEBO\" target=\"_blank\">PEBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589863-peoples-bancorp-tapped-at-strong-buy-at-rayjay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">People&#39;s Bancorp tapped at Strong Buy at RayJay</a></h4><ul><li>People's Bancorp (<a href=\"https://seekingalpha.com/symbol/PEBO\" title=\"Peoples Bancorp Inc.\">PEBO</a> <font color=\"green\">+3%</font>) continues a big February run after catching the eye of Raymond James <a href=\"http://www.streetinsider.com/Upgrades/Raymond+James+Upgrades+Peoples+Bancorp+%28PEBO%29+to+Strong+Buy/9210811.html\" target=\"_blank\">which moves </a>the $250M market cap lender onto its Strong Buy list (from Outperform previously) with price target of $28.</li></ul><div class=\"tiny-share-widget\" data-id=\"1589863\" data-linked=\"People&#39;s Bancorp tapped at Strong Buy at RayJay\" data-tweet=\"$PEBO - People&#39;s Bancorp tapped at Strong Buy at RayJay https://seekingalpha.com/news/1589863-peoples-bancorp-tapped-at-strong-buy-at-rayjay?source=tweet\" data-url=\"https://seekingalpha.com/news/1589863-peoples-bancorp-tapped-at-strong-buy-at-rayjay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589843\" data-ts=\"1393344503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589843-biocryst-pharma-plus-12-percent-after-fda-accepts-nda-for-peramivir\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCryst Pharma +12% after FDA accepts NDA for peramivir</a></h4><ul>\n<li>The NDA is assigned a standard review time, putting the PDUFA action date at December 23 of this year (early enough for flu season). At this time, the FDA does not plan on holding an AdCom review.</li>\n<li>While FDA acceptances are typical \"check the box\" events, this is BioCryst's (<a href=\"https://seekingalpha.com/symbol/BCRX\" title=\"BioCryst Pharmaceuticals, Inc.\">BCRX</a> <font color=\"green\">+12.1%</font>) first NDA submission and \"thus an important corporate achievement,\" says Needham's Serge Belanger,<a href=\"http://www.streetinsider.com/Analyst+Comments/BioCryst+Pharma+%28BCRX%29+Peramivir+NDA+Acceptance+an+Important+Achievement%2C+Needham+%26+Company+Says/9212783.html\" target=\"_blank\"> reiterating his Buy</a> and $14 price target.</li>\n<li>\"Peramivir could potentially be available for the 2014-2015 flu season ... Given the government's continuing financial support (total of $235M in contracts) of the peramivir program and its unapproved public use in 2009 under emergency use authorization, we believe there is support for the potential approval of the first IV-administered influenza treatment. We have not included peramivir projections in our financial model since we believe the main revenue potential will be from government stockpiling, which have extremely low visibility.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589843\" data-linked=\"BioCryst Pharma +12% after FDA accepts NDA for peramivir\" data-tweet=\"$BCRX - BioCryst Pharma +12% after FDA accepts NDA for peramivir https://seekingalpha.com/news/1589843-biocryst-pharma-plus-12-percent-after-fda-accepts-nda-for-peramivir?source=tweet\" data-url=\"https://seekingalpha.com/news/1589843-biocryst-pharma-plus-12-percent-after-fda-accepts-nda-for-peramivir\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589773\" data-ts=\"1393342537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSEC\" target=\"_blank\">PSEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589773-bdcs-under-pressure-as-leaders-removed-from-s-and-p-indices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BDCs under pressure as leaders removed from S&amp;P indices</a></h4><ul>\n<li>Amid <a href=\"https://seekingalpha.com/news/1589443-8x8-universal-insurance-to-join-s-and-p-smallcap-600-knowles-to-midcap-400\" target=\"_blank\">the dropping</a> of Prospect Capital (<a href=\"https://seekingalpha.com/symbol/PSEC\" title=\"Prospect Capital Corporation\">PSEC</a> <font color=\"red\">-3%</font>) from the S&amp;P SmallCap 600 and Apollo Investment from the S&amp;P MidCap 400, the business development sector is reeling a bit.</li>\n<li>Ares Capital (<a href=\"https://seekingalpha.com/symbol/ARCC\" title=\"Ares Capital\">ARCC</a> <font color=\"red\">-1.5%</font>), Main Street (<a href=\"https://seekingalpha.com/symbol/MAIN\" title=\"Main Street Capital\">MAIN</a> <font color=\"red\">-1.8%</font>), Blackrock Kelso (<a href=\"https://seekingalpha.com/symbol/BKCC\" title=\"BlackRock Capital Investment Corporation\">BKCC</a> <font color=\"red\">-3.3%</font>), Triangle (<a href=\"https://seekingalpha.com/symbol/TCAP-OLD\" title=\"Triangle Capital\">TCAP-OLD</a> <font color=\"red\">-2.2%</font>), TICC Capital (TICC <font color=\"red\">-1.2%</font>), PennantPark (<a href=\"https://seekingalpha.com/symbol/PNNT\" title=\"PennantPark Investment\">PNNT</a> <font color=\"red\">-2.7%</font>), THL Credit (<a href=\"https://seekingalpha.com/symbol/TCRD\" title=\"THL Credit\">TCRD</a> <font color=\"red\">-1.2%</font>), Hercules Technology (<a href=\"https://seekingalpha.com/symbol/HTGC\" title=\"Hercules Capital, Inc.\">HTGC</a> <font color=\"red\">-2.6%</font>).</li>\n<li>BDC ETFs: <a href=\"https://seekingalpha.com/symbol/BDCL\" title=\"UBS ETRACS 2X Leveraged Long Wells Fargo Business Development Company ETN\">BDCL</a>, <a href=\"https://seekingalpha.com/symbol/BDCS\" title=\"UBS ETRACS Wells Fargo Business Development Company ETN\">BDCS</a>, <a href=\"https://seekingalpha.com/symbol/BIZD\" title=\"VanEck Vectors BDC Income ETF\">BIZD</a>\n</li>\n<li>See also: <a href=\"https://seekingalpha.com/news/1589463-apollo-investment-minus-5_9-percent-amid-secondary-and-index-changes\" target=\"_blank\">AINV with</a> 12M share secondary</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589773\" data-linked=\"BDCs under pressure as leaders removed from S&amp;P indices\" data-tweet=\"$PSEC $PSEC $ARCC - BDCs under pressure as leaders removed from S&amp;P indices https://seekingalpha.com/news/1589773-bdcs-under-pressure-as-leaders-removed-from-s-and-p-indices?source=tweet\" data-url=\"https://seekingalpha.com/news/1589773-bdcs-under-pressure-as-leaders-removed-from-s-and-p-indices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589743\" data-ts=\"1393341926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589743-macys-leads-department-store-sector-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s leads department store sector higher</a></h4><ul> <li>Investors are giving Macy's (<a href=\"https://seekingalpha.com/symbol/M\" title=\"Macy's Inc.\">M</a> <font color=\"green\">+3.9%</font>) a pass after January sales came in soft and the company warned on a sluggish early start to the current quarter.</li> <li>The enthusiasm on the retailer appears to stem from its ability to hold up margins through its omnichannel approach to selling.</li> <li>Macy's also reiterated its guidance for the fiscal year despite the slow start.</li> <li>The department store sector is mounting a little comeback today after it was awash in red yesterday.</li> <li>Gainers: Kohl's (NYSE:<a href=\"https://seekingalpha.com/symbol/KSS\" title=\"Kohl's Corporation\">KSS</a>) <font color=\"green\">+1.8%</font>, Nordstrom <font color=\"green\">+0.8%</font>, Dillard's (NYSE:<a href=\"https://seekingalpha.com/symbol/DDS\" title=\"Dillard's Inc.\">DDS</a>) <font color=\"green\">+4.6%</font>, Sears Holdings (SHLD) <font color=\"green\">+3.3%</font>, Bon-Ton Stores (<a href=\"https://seekingalpha.com/symbol/BONT\" title=\"The Bon-Ton Stores, Inc.\">OTC:BONT</a>) <font color=\"green\">+2.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589743\" data-linked=\"Macy&#39;s leads department store sector higher\" data-tweet=\"$M $M $KSS - Macy&#39;s leads department store sector higher https://seekingalpha.com/news/1589743-macys-leads-department-store-sector-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1589743-macys-leads-department-store-sector-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589733\" data-ts=\"1393341641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAX\" target=\"_blank\">RAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589733-rackspace-higher-after-cancelling-conference-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rackspace higher after cancelling conference presentation</a></h4><ul>\n<li>Bloomberg reports Rackspace (<a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a> <font color=\"green\">+5.3%</font>) has cancelled a presentation at an Oppenheimer cloud services conference set for next month, while citing a scheduling conflict. Shares have jumped in response.</li>\n<li>The cancellation comes in the wake of CEO Lanham Napier's <a href=\"https://seekingalpha.com/news/1559301-rackspace-ceo-retires-co-founder-chairman-to-act-as-interim-ceo\" target=\"_blank\">retirement</a>. 16% of Rackspace's float was shorted as of Jan. 31.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589733\" data-linked=\"Rackspace higher after cancelling conference presentation\" data-tweet=\"$RAX - Rackspace higher after cancelling conference presentation https://seekingalpha.com/news/1589733-rackspace-higher-after-cancelling-conference-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/1589733-rackspace-higher-after-cancelling-conference-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589703\" data-ts=\"1393341233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589703-gamestop-rallies-with-rumors-in-the-air\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop rallies with rumors in the air</a></h4><ul> <li>Shares of GameStop (<a href=\"https://seekingalpha.com/symbol/GME\" title=\"GameStop Corp.\">GME</a> <font color=\"green\">+5.4%</font>) are active on market chatter that an activist investor is prepping to make a move.</li> <li>Option activity is also running at above-normal levels.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1589703\" data-linked=\"GameStop rallies with rumors in the air\" data-tweet=\"$GME - GameStop rallies with rumors in the air https://seekingalpha.com/news/1589703-gamestop-rallies-with-rumors-in-the-air?source=tweet\" data-url=\"https://seekingalpha.com/news/1589703-gamestop-rallies-with-rumors-in-the-air\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589693\" data-ts=\"1393340958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589693-blackberry-rallies-new-phones-launched-chen-open-to-bbm-sale-spinoff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry rallies. New phones launched, Chen open to BBM sale/spinoff.</a></h4><ul>\n<li>Up yesterday following news Ford is <a href=\"https://seekingalpha.com/news/1585453-bloomberg-blackberry-to-get-major-boost-from-ford\" target=\"_blank\">set to use QNX</a> within its next-gen Sync system, BlackBerry (BBRY <font color=\"green\">+6.6%</font>) is gaining today following the unveiling of several products, and <a href=\"http://www.bloomberg.com/news/2014-02-25/blackberry-sees-increase-in-messaging-users-after-whatsapp-deal.html\" target=\"_blank\">remarks</a> from John Chen suggesting he's open to selling or spinning off BBM down the road.</li>\n<li>Chen, referencing the $19B Facebook/WhatsApp deal: \"Anything to help our shareholders I need to take a very serious look at ... The potential [for BBM] is going to be huge ... Until we get to the point that we can showcase that potential it is a bit too early to think about getting our $19 billion.\"</li>\n<li>Shares jumped last week in response to Facebook/WhatsApp. <a href=\"https://seekingalpha.com/news/1581743-td-values-bbm-at-800m-after-facebook-whatsapp-tencent-naver-sell-off\" target=\"_blank\">TD Securities </a>upped its estimated valuation for BBM to $800M.</li>\n<li>This morning, BlackBerry has launched the Z3, a 5\" touch-only phone that will sell for less than $200 unsubsidized in Indonesia (one of BlackBerry's biggest markets) starting in April, and the Q20, a new QWERTY flagship. The Z3, which doesn't sport a 4G modem for now, is the product of BlackBerry's Foxconn partnership.</li>\n<li>Also announced: 1) The eBBM Suite (launching this summer), a set of secure messaging products/services built with enterprises in mind. 2) BES 12 (launching by year's end), a next-gen MDM software platform offering better app/service management. 3) A promotional program that allows enterprises to migrate to BES 10 for free.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589693\" data-linked=\"BlackBerry rallies. New phones launched, Chen open to BBM sale/spinoff.\" data-tweet=\"$BB - BlackBerry rallies. New phones launched, Chen open to BBM sale/spinoff. https://seekingalpha.com/news/1589693-blackberry-rallies-new-phones-launched-chen-open-to-bbm-sale-spinoff?source=tweet\" data-url=\"https://seekingalpha.com/news/1589693-blackberry-rallies-new-phones-launched-chen-open-to-bbm-sale-spinoff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589683\" data-ts=\"1393340954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITMN\" target=\"_blank\">ITMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589683-intermune-shares-more-than-double-following-trial-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intermune shares more than double following trial results</a></h4><ul>   <li>InterMune (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ITMN\" title=\"InterMune, Inc.\">ITMN</a>) shares <font color=\"green\">rocket 122%</font> after the company's  Pirfenidone treatment for the idiopathic pulmonary fibrosis <a href=\"https://seekingalpha.com/news/1588823-intermunes-pirfenidone-meets-phase-iii-trial-goals\" target=\"_blank\">met primary and secondary endpoints</a> in a Phase III trial.</li>    <li>The results mark a turnaround for Pirfenidone, which the FDA rejected in May 2010 due to a lack of evidence for the efficacy of  Pirfenidone in treating the lung disease.</li>    <li>In the trial, 16.5% of patients receiving Pirfenidone <a href=\"http://www.reuters.com/article/2014/02/25/intermune-study-lungdrug-idUSL3N0LU3KG20140225\" target=\"_blank\">suffered disease progression</a> after 52 weeks of treatment vs 31.8% taking a placebo. In addition, 22.7% of those getting the drug experienced no decline in lung function vs 9.7% with the placebo. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589683\" data-linked=\"Intermune shares more than double following trial results\" data-tweet=\"$ITMN - Intermune shares more than double following trial results https://seekingalpha.com/news/1589683-intermune-shares-more-than-double-following-trial-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1589683-intermune-shares-more-than-double-following-trial-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589633\" data-ts=\"1393340168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FE\" target=\"_blank\">FE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589633-firstenergy-minus-1_6-percent-as-q4-revenue-misses-estimates-guides-q1-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FirstEnergy -1.6% as Q4 revenue misses estimates, guides Q1 lower</a></h4><ul>     <li>FirstEnergy (<a href=\"https://seekingalpha.com/symbol/FE\" title=\"FirstEnergy Corp\">FE</a> <font color=\"red\">-1.6%</font>) swung to a <a href=\"https://seekingalpha.com/news/1589203-firstenergy-corp-beats-by-0_06-misses-on-revenue\" target=\"_blank\">Q4 profit</a> but revenue missed expectations and the power company issued downside guidance for Q1 earnings.</li>     <li>FE says Q4 operating earnings benefited from higher distribution revenues, higher regulated generation operating margin, and increased investment income and lower interest expense compared to the prior-year period.</li>     <li>Q4 distribution deliveries rose 4% Y/Y, largely due to colder temperatures compared to the year-ago quarter, which drove a 3% increase in sales to both residential and commercial customers.</li>     <li>Sees Q1 EPS of $0.35-$0.45 vs. $0.63 analyst consensus estimate, but issues in-line guidance for FY 2014, seeing EPS of $2.45-$2.85 vs. $2.69 consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589633\" data-linked=\"FirstEnergy -1.6% as Q4 revenue misses estimates, guides Q1 lower\" data-tweet=\"$FE - FirstEnergy -1.6% as Q4 revenue misses estimates, guides Q1 lower https://seekingalpha.com/news/1589633-firstenergy-minus-1_6-percent-as-q4-revenue-misses-estimates-guides-q1-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1589633-firstenergy-minus-1_6-percent-as-q4-revenue-misses-estimates-guides-q1-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589603\" data-ts=\"1393339933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTP\" target=\"_blank\">MTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589603-fda-grants-orphan-drug-status-to-daras-pain-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA grants Orphan Drug status to Dara&#39;s pain drug</a></h4><ul>   <li>Dara Biosciences' (DARA) <font color=\"green\">surges 39.4%</font> after the FDA grants Orphan Drug Designation to the company's KRN5500 treatment for chronic neuropathic pain caused by chemotherapy.</li>    <li>Dara is now looking at funding options for the further development of KRN5500.</li>     <li>Earlier this month, Jason Napodano of Zacks wrote that \"orphan drug designation on KRN5500 could <a href=\"https://seekingalpha.com/article/2007691-still-betting-on-dara-bio\" target=\"_blank\">triple the market value</a>\" of Dara.</li>\n<li>Napodano also expected the company to bring in a licensing partner once Orphan Drug status was secured. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589603\" data-linked=\"FDA grants Orphan Drug status to Dara&#39;s pain drug\" data-tweet=\"$MTP - FDA grants Orphan Drug status to Dara&#39;s pain drug https://seekingalpha.com/news/1589603-fda-grants-orphan-drug-status-to-daras-pain-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/1589603-fda-grants-orphan-drug-status-to-daras-pain-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589563\" data-ts=\"1393339032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRVO\" target=\"_blank\">QRVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589563-tech-ratings-changes-rf-micro-triquint-tivo-realpage-datawatch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech ratings changes: RF Micro, TriQuint, TiVo, RealPage, Datawatch</a></h4><ul>\n<li>RF Micro (RFMD <font color=\"red\">-2.4%</font>) has been cut to Hold by Canaccord, and to Neutral by D.A. Davidson, after soaring yesterday in response to news it's <a href=\"https://seekingalpha.com/news/1586043-merger-of-equals-between-rf-micro-devices-and-triquint-semiconductor\" target=\"_blank\">merging</a> with RF component rival TriQuint (TQNT <font color=\"red\">-0.9%</font>). TriQuint has also been cut to Neutral by D.A. Davidson, and upgraded to Buy by Brean.</li>\n<li>TiVo (<a href=\"https://seekingalpha.com/symbol/TIVO\" title=\"TiVo Inc.\">TIVO</a> <font color=\"green\">+1.1%</font>) has been started at Outperform by Northland.</li>\n<li>RealPage (<a href=\"https://seekingalpha.com/symbol/RP\" title=\"RealPage\">RP</a> <font color=\"red\">-22.7%</font>) has been cut to Sector Perform by RBC after posting <a href=\"https://seekingalpha.com/news/1587543-realpage-beats-by-0_01-misses-on-revenue\" target=\"_blank\">mixed Q4 results</a> and providing soft 2014 guidance (revenue of $440M-$450M and EPS of $0.65-$0.69 vs. a consensus of $459.7M and $0.76).</li>\n<li>Datawatch (<a href=\"https://seekingalpha.com/symbol/DWCH\" title=\"Datawatch Corporation\">DWCH</a> <font color=\"green\">+6.1%</font>) has been started at Outperform by Cowen.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589563\" data-linked=\"Tech ratings changes: RF Micro, TriQuint, TiVo, RealPage, Datawatch\" data-tweet=\"$QRVO $QRVO $TIVO - Tech ratings changes: RF Micro, TriQuint, TiVo, RealPage, Datawatch https://seekingalpha.com/news/1589563-tech-ratings-changes-rf-micro-triquint-tivo-realpage-datawatch?source=tweet\" data-url=\"https://seekingalpha.com/news/1589563-tech-ratings-changes-rf-micro-triquint-tivo-realpage-datawatch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589533\" data-ts=\"1393338784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589533-citi-buying-the-dip-in-ocwen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi buying the dip in Ocwen</a></h4><ul><li>Launching coverage in the recently beat-up nonbank servicing sector Citigroup starts Ocwen Financial (<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>&nbsp;<font color='green'>+0.3%</font>) and New Residential (<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a>&nbsp;<font color='green'>+0.9%</font>) with Buys, and Nationstar Mortgage (<a href='https://seekingalpha.com/symbol/NSM' title='Nationstar Mortgage Holdings'>NSM</a>&nbsp;<font color='green'>+0.2%</font>) at Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"1589533\" data-linked=\"Citi buying the dip in Ocwen\" data-tweet=\"$OCN $OCN $NRZ - Citi buying the dip in Ocwen https://seekingalpha.com/news/1589533-citi-buying-the-dip-in-ocwen?source=tweet\" data-url=\"https://seekingalpha.com/news/1589533-citi-buying-the-dip-in-ocwen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589473\" data-ts=\"1393337908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HD\" target=\"_blank\">HD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589473-home-depot-impresses-lifts-lowes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Home Depot impresses, lifts Lowe&#39;s</a></h4><ul> <li>Shares of Home Depot (NYSE:<a href=\"https://seekingalpha.com/symbol/HD\" title=\"Home Depot, Inc.\">HD</a>) are higher after the company <a href=\"https://seekingalpha.com/news/1588523-home-depot-puts-in-another-solid-quarter\" target=\"_blank\">topped</a> estimates with its costs firmly under control.</li> <li>The company's performance in maintaining store traffic during a tough weather period is even more impressive considering the tough comparable it came up against with Superstorm Sandy recovery a significant factor a year ago.</li> <li>HD <font color=\"green\">+2.0%</font> premarket, while rival Lowe's (NYSE:<a href=\"https://seekingalpha.com/symbol/LOW\" title=\"Lowe's Companies, Inc.\">LOW</a>) is getting a <font color=\"green\">1% sympathy boost</font>. Lowe's has its turn to release Q4 numbers tomorrow.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589473\" data-linked=\"Home Depot impresses, lifts Lowe&#39;s\" data-tweet=\"$HD $HD $LOW - Home Depot impresses, lifts Lowe&#39;s https://seekingalpha.com/news/1589473-home-depot-impresses-lifts-lowes?source=tweet\" data-url=\"https://seekingalpha.com/news/1589473-home-depot-impresses-lifts-lowes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589463\" data-ts=\"1393337869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AINV\" target=\"_blank\">AINV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589463-apollo-investment-minus-5_9-percent-amid-secondary-and-index-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Investment -5.9% amid secondary and index changes</a></h4><ul>\n<li>Offered are 12M shares with underwriter greenshoe of 1.8M shares. The current float is 239M shares. Net proceeds are expected to be used to repay Apollo's credit line.</li>\n<li>Earlier: <a href=\"https://seekingalpha.com/news/1589443\" target=\"_blank\">AINV removed </a>from S&amp;P MidCap 400</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/AINV\" title=\"Apollo Investment\">AINV</a> <font color=\"red\">-5.8%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589463\" data-linked=\"Apollo Investment -5.9% amid secondary and index changes\" data-tweet=\"$AINV - Apollo Investment -5.9% amid secondary and index changes https://seekingalpha.com/news/1589463-apollo-investment-minus-5_9-percent-amid-secondary-and-index-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1589463-apollo-investment-minus-5_9-percent-amid-secondary-and-index-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589443\" data-ts=\"1393337549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGHT\" target=\"_blank\">EGHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589443-8x8-universal-insurance-to-join-s-and-p-smallcap-600-knowles-to-midcap-400\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">8x8, Universal Insurance to join S&amp;P SmallCap 600, Knowles to MidCap 400</a></h4><ul>\n<li>8x8 Inc. (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EGHT\" title=\"8X8 Inc\">EGHT</a>) <font color=\"green\">+4.8%</font> premarket and Universal Insurance (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/UVE\" title=\"Universal Insurance Holdings, Inc\">UVE</a>) <font color=\"green\">+2.7%</font> as the companies are selected to <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/79668_dovspinbdc46.pdf?force_download=true\" target=\"_blank\">join the S&amp;P SmallCap 600</a> after the close of trading Feb. 28; EGHT and UVE will replace Prospect Capital (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PSEC\" title=\"Prospect Capital Corporation\">PSEC</a>) and Avid Technology (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AVID\" title=\"Avid Technology, Inc.\">AVID</a>), respectively.</li>\n<li>Also, Knowles Corp. will be added to the S&amp;P MidCap 400 as it is spun off from S&amp;P 500 constituent Dover (NYSE:<a href=\"https://seekingalpha.com/symbol/DOV\" title=\"Dover Corp\">DOV</a>) to  shareholders, effective after the close  of trading Feb. 28; DOV will remain in the S&amp;P 500 after the  spinoff; Knowles, which will use the ticker symbol KN, is replacing Apollo Investment (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AINV\" title=\"Apollo Investment\">AINV</a>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589443\" data-linked=\"8x8, Universal Insurance to join S&amp;P SmallCap 600, Knowles to MidCap 400\" data-tweet=\"$EGHT $EGHT $UVE - 8x8, Universal Insurance to join S&amp;P SmallCap 600, Knowles to MidCap 400 https://seekingalpha.com/news/1589443-8x8-universal-insurance-to-join-s-and-p-smallcap-600-knowles-to-midcap-400?source=tweet\" data-url=\"https://seekingalpha.com/news/1589443-8x8-universal-insurance-to-join-s-and-p-smallcap-600-knowles-to-midcap-400\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589433\" data-ts=\"1393337482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589433-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> DARA <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/MSO' title='BlackRock Multi-Sector Opportunities Trust'>MSO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ZU' title='Zulily, Inc.'>ZU</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VSI' title='Vitamin Shoppe, Inc.'>VSI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/XOMA' title='XOMA Corporation'>XOMA</a> <font color='green'>+7%</font>. CLDN <font color='green'>+6%</font></li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RP' title='RealPage'>RP</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/ODP' title='Office Depot Inc.'>ODP</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/AINV' title='Apollo Investment'>AINV</a> <font color='red'>-6%</font>. WPCS <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589433\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$MTP $IMUC $LTRX - Premarket Gainers / Losers https://seekingalpha.com/news/1589433-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1589433-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589393\" data-ts=\"1393336952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589393-vivus-shares-tumble-following-earnings-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus shares tumble following earnings report</a></h4><ul>    <li>Vivus (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a>) <font color=\"red\">slumps 13.9%</font> to $5.81 despite the company's <a href=\"https://seekingalpha.com/news/1587353-vivus-inc-beats-by-0_23-beats-on-revenue\" target=\"_blank\">Q4 earnings beat</a>.</li>    <li>However, as SA author Spencer Osborne <a href=\"https://seekingalpha.com/article/2045683-vivus-beats-the-street-sort-of?source=google_news\" target=\"_blank\">points out</a>, EPS only topped forecasts because of a one-time licensing payment of $34.8M for Vivus' erectile dysfunction drug.</li>    <li>Sales of  anti-obesity drug Qsymia were $7.7M, in line with estimates at Needham.</li>    <li>Qsymia prescriptions +14% on quarter to 124,000.</li>    <li>Needham analyst Alan Carr notes that management was <a href=\"http://www.streetinsider.com/Analyst+Comments/Vivus+%28VVUS%29+Qsymia+Sales+Lackluster+and+Partner+Continues+to+be+a+Challenge%3A+Needham+%26+Company/9211709.html\" target=\"_blank\">disappointed with sales levels</a>, and \"outlined plans to improve physician and patient education as well as revenue/prescription in 2014.\"</li>    <li>Qsymia brought in $62.09 per prescription filled in Q4.</li>    <li>Net loss narrowed to $17.2M from $56.7M a year earlier.</li>    <li>Carr reiterates his Hold rating on Vivus, although BofA <a href=\"https://twitter.com/search?q=%24vvus%20%40thenotablecalls&amp;src=typd\" target=\"_blank\">cuts its rating</a> to Underperform and sets a price target of $6. BofA cites a looming capital raising and falling expectations about Vivus' ability to sign up a quality partner. Jeffco slashes its PT to $2 from $5. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589393\" data-linked=\"Vivus shares tumble following earnings report\" data-tweet=\"$VVUS - Vivus shares tumble following earnings report https://seekingalpha.com/news/1589393-vivus-shares-tumble-following-earnings-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1589393-vivus-shares-tumble-following-earnings-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589343\" data-ts=\"1393336585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589343-seadrill-paints-gloomy-drilling-market-outlook-minus-4_9-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill paints gloomy drilling market outlook, -4.9% premarket</a></h4><ul>\n<li>Seadrill (NYSE:<a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a>) <font color=\"red\">-4.9%</font> premarket after posting a rise in <a href=\"https://seekingalpha.com/news/1588353-seadrill-limited-eps-of-0_49\" target=\"_blank\">Q4 earnings</a> but warning of possible market challenges this year as some projects  face delays.</li>\n<li>Oil companies currently have <a href=\"http://www.reuters.com/article/2014/02/25/seadrill-results-idUSL6N0LU19220140225\" target=\"_blank\">limited opportunities to fund exploration activities</a>, thanks to relatively high dividend payouts and increasing development costs to bring new production on stream, SDRL says, thus \"2014 and 2015 may show slower growth in activity levels than earlier anticipated.\"</li>\n<li>SDRL had been adding ultradeep drilling vessels in recent years, but now says it will focus on its existing fleet until it sees oil companies raise spending.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589343\" data-linked=\"Seadrill paints gloomy drilling market outlook, -4.9% premarket\" data-tweet=\"$SDRL - Seadrill paints gloomy drilling market outlook, -4.9% premarket https://seekingalpha.com/news/1589343-seadrill-paints-gloomy-drilling-market-outlook-minus-4_9-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1589343-seadrill-paints-gloomy-drilling-market-outlook-minus-4_9-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589323\" data-ts=\"1393336521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSBC\" target=\"_blank\">HSBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589323-two-downgrades-for-hsbc-following-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two downgrades for HSBC following earnings</a></h4><ul><li>After a tough day yesterday <a href=\"https://seekingalpha.com/news/1586343-more-on-the-hsbc-earnings-miss\" target=\"_blank\">post-disappointing earnings</a>, <a href=\"https://seekingalpha.com/symbol/HSBC\" title=\"HSBC Holdings PLC\">HSBC</a> is off <font color=\"red\">another 1.2%</font> premarket after Citigroup and JPMorgan each remove Buy ratings on the stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"1589323\" data-linked=\"Two downgrades for HSBC following earnings\" data-tweet=\"$HSBC - Two downgrades for HSBC following earnings https://seekingalpha.com/news/1589323-two-downgrades-for-hsbc-following-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1589323-two-downgrades-for-hsbc-following-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589253\" data-ts=\"1393335362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNDI\" target=\"_blank\">KNDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589253-kandi-surging-for-second-day-on-electric-car-expansion-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kandi surging for second day on electric car expansion plan</a></h4><ul>\n<li>Kandi Technologies (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KNDI\" title=\"Kandi Technologies Group, Inc.\">KNDI</a>) <font color=\"green\">+2.8%</font> premarket on top of yesterday's 16% surge after the Chinese electric car rental company said is profitable and that it <a href=\"http://www.bloomberg.com/news/2014-02-25/kandi-surges-16-to-record-on-electric-car-expansion-plan.html\" target=\"_blank\">plans to expand</a> to the country\u2019s biggest cities.</li>\n<li>KNDI is selecting local partners in Shanghai, Beijing and Chengdu, Chairman Hu Xiaoming said.</li>\n<li>However, shares could be weighed later in the day by a <em>WantChinaTimes</em> article that says China's promotion for new energy cars is <a href=\"http://www.wantchinatimes.com/news-subclass-cnt.aspx?cid=1202&amp;MainCatID=12&amp;id=20140225000040\" target=\"_blank\">not going well</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589253\" data-linked=\"Kandi surging for second day on electric car expansion plan\" data-tweet=\"$KNDI - Kandi surging for second day on electric car expansion plan https://seekingalpha.com/news/1589253-kandi-surging-for-second-day-on-electric-car-expansion-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/1589253-kandi-surging-for-second-day-on-electric-car-expansion-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589183\" data-ts=\"1393334589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ODP\" target=\"_blank\">ODP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589183-faith-crumbling-in-office-supply-chains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Faith crumbling in office supply chains</a></h4><ul> <li>Shares of Office Depot (NYSE:<a href=\"https://seekingalpha.com/symbol/ODP\" title=\"Office Depot Inc.\">ODP</a>) tumble in early action after the company's <a href=\"https://seekingalpha.com/news/1588573-more-on-office-depots-q4\" target=\"_blank\">Q4 report</a> shows underlying weakness despite the Office Depot-OfficeMax combination.</li> <li>The quick analyst take is that the integration of the two big box chains is proving tricky with synergies still off in the distance. A strong quarterly report from Home Depot for an overlapping period makes Office Depot look even weaker.</li> <li>Staples (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPLS\" title=\"Staples, Inc.\">SPLS</a>) investors have taken notice of the development. SPLS <font color=\"red\">-3.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589183\" data-linked=\"Faith crumbling in office supply chains\" data-tweet=\"$ODP $ODP $SPLS - Faith crumbling in office supply chains https://seekingalpha.com/news/1589183-faith-crumbling-in-office-supply-chains?source=tweet\" data-url=\"https://seekingalpha.com/news/1589183-faith-crumbling-in-office-supply-chains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589153\" data-ts=\"1393334142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589153-macys-lower-after-jan-sales-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s lower after Jan. sales disappoint</a></h4><ul> <li>Macy's (NYSE:<a href=\"https://seekingalpha.com/symbol/M\" title=\"Macy's Inc.\">M</a>) announces comparable-store sales rose 1.4% in <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=84477&amp;p=irol-newsArticle&amp;ID=1903138&amp;highlight=\" target=\"_blank\">Q4</a>, a mark which improves to 4.3% if sales from departments licensed to third parties is included.</li> <li>The retailer says it's \"very disappointed\" with its poor sales performance in January amid harsh winter weather. The month saw a 7%-8% drop in comp sales.</li> <li>Gross margin rate was flat from the year-ago period indicating sell-through prices held up for the company better than most peers.</li> <li>Guidance for comparable sales growth in FY14 is set at 2.5%-3.0%.</li> <li>M <font color=\"red\">-2.1%</font> premarket</li> </ul><div class=\"tiny-share-widget\" data-id=\"1589153\" data-linked=\"Macy&#39;s lower after Jan. sales disappoint\" data-tweet=\"$M - Macy&#39;s lower after Jan. sales disappoint https://seekingalpha.com/news/1589153-macys-lower-after-jan-sales-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/1589153-macys-lower-after-jan-sales-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1589133\" data-ts=\"1393334044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1589133-linkedin-launches-chinese-language-site\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LinkedIn launches Chinese language site</a></h4><ul>\n<li>LinkedIn (LNKD) is <font color=\"green\">ahead by 2.6%</font> in the premarket <a href=\"http://www.streetinsider.com/Analyst+Comments/LinkedIn+%28LNKD%29+Expands+in+China+with+Chinese+Language+Site/9211429.html\" target=\"_blank\">after moving forward in China</a> with the opening of a beta Simplified Chinese language site. The company already has 4M Chinese users on its English version, and the Chinese site will broaden reach to 140M Chinese professional workers.</li>\n<li>Of course, operating in-country will draw more attention from Beijing's censors, but Wunderlich's Blake Harper thinks LinkedIn \"has less to concede than many other western Internet companies, as its core mission and use case for professionals is in line with the government's initiatives for economic growth ... If all goes as planned, the company should see material member growth and engagement on the site throughout the year, but we would expect any impact with corporate customers to be further down the road.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1589133\" data-linked=\"LinkedIn launches Chinese language site\" data-tweet=\"$MSFT - LinkedIn launches Chinese language site https://seekingalpha.com/news/1589133-linkedin-launches-chinese-language-site?source=tweet\" data-url=\"https://seekingalpha.com/news/1589133-linkedin-launches-chinese-language-site\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1588953\" data-ts=\"1393332742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1588953-tesla-motors-races-higher-on-morgan-stanley-pt-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors races higher on Morgan Stanley PT hike</a></h4><ul> <li>Shares of Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) are revving higher in early trading after Morgan Stanley more than <a href=\"https://twitter.com/Lebeaucarnews/status/438291747177639936\" target=\"_blank\">doubles</a> its price target to $320 from $153.</li> <li>The investment firm assumes unit volume from Tesla will soar and that the company could be disruptive in the utility market.</li> <li>TSLA <font color=\"green\">+6.8%</font> premarket to $232.44</li> </ul><div class=\"tiny-share-widget\" data-id=\"1588953\" data-linked=\"Tesla Motors races higher on Morgan Stanley PT hike\" data-tweet=\"$TSLA - Tesla Motors races higher on Morgan Stanley PT hike https://seekingalpha.com/news/1588953-tesla-motors-races-higher-on-morgan-stanley-pt-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/1588953-tesla-motors-races-higher-on-morgan-stanley-pt-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1588523\" data-ts=\"1393328922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HD\" target=\"_blank\">HD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1588523-home-depot-puts-in-another-solid-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Home Depot puts in another solid quarter</a></h4><ul> <li>Home Depot (NYSE:<a href=\"https://seekingalpha.com/symbol/HD\" title=\"Home Depot, Inc.\">HD</a>) reports that comparable-store sales rose 4.4% in Q4.</li> <li>Comp sales in the U.S. rose 4.9% during the period.</li> <li>Total expenses fell 4% in Q4 to $4.43B as the company lightened up on SG&amp;A costs.</li> <li>For FY14, Home Depot sees sales growth of 4.8% and operating margin expansion of 70 bps. EPS is expected to land at $4.38.</li> <li>HD <font color=\"green\">+0.4%</font> premarket</li> </ul><div class=\"tiny-share-widget\" data-id=\"1588523\" data-linked=\"Home Depot puts in another solid quarter\" data-tweet=\"$HD - Home Depot puts in another solid quarter https://seekingalpha.com/news/1588523-home-depot-puts-in-another-solid-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/1588523-home-depot-puts-in-another-solid-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1588323\" data-ts=\"1393324309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1588323-asian-shares-mixed-europe-mainly-drops\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian shares mixed, Europe mainly drops</a></h4><ul>   <li>\n<a href=\"http://www.bloomberg.com/news/2014-02-24/asia-futures-gain-as-won-forwards-signal-rally-oil-rises.html\" target=\"_blank\">Asian shares</a> are mixed but European equities and U.S. stock futures mostly trade lower.</li>    <li>Chinese shares add to yesterday's sharp drop and <font color=\"red\">fall 2%</font> amid ongoing concerns about the property sector and amid a sliding yuan. The further draining of money from the financial system by the PBOC is also not helping.</li>    <li>However, Japanese shares <font color=\"green\">rise 1.4%</font> as stocks again make sharp daily moves, which have been going in either direction lately.</li>    <li>In Europe, the mood has been dampened by disappointing earnings reports from the likes of Vivendi and Fresenius.</li>    <li>Elsewhere in Asia, Hong Kong <font color=\"red\">-0.3%</font>, India <font color=\"green\">+0.2%</font>.</li>    <li>Euro Stoxx 50 <font color=\"red\">-0.15%</font>, London <font color=\"red\">-0.6%</font>, Paris <font color=\"red\">-0.5%</font>, Frankfurt <font color=\"red\">-0.3%</font>, Milan <font color=\"red\">-0.4%</font>, Madrid <font color=\"green\">+0.2%</font>.</li>     <li>U.S. stock futures: Dow <font color=\"red\">-0.1%</font>. S&amp;P <font color=\"red\">-0.1%</font>. Nasdaq <font color=\"red\">-0.1%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1588323\" data-linked=\"Asian shares mixed, Europe mainly drops\" data-tweet=\"Asian shares mixed, Europe mainly drops https://seekingalpha.com/news/1588323-asian-shares-mixed-europe-mainly-drops?source=tweet\" data-url=\"https://seekingalpha.com/news/1588323-asian-shares-mixed-europe-mainly-drops\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1588303\" data-ts=\"1393322076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTCS\" target=\"_blank\">BTCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1588303-bitcoin-plunges-as-major-exchange-goes-dark\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin plunges as major exchange goes dark</a></h4><ul>   <li>The price of Bitcoin has <font color=\"red\">plummeted 11.2%</font> to $484.35 after one of its leading exchanges, Mt Gox, <a href=\"http://www.forbes.com/sites/andygreenberg/2014/02/25/bitcoins-price-plummets-as-mt-gox-goes-dark-with-massive-hack-rumored/\" target=\"_blank\">appeared to have disappeared</a> amid speculation of a massive security breach and that it's about to go bankrupt.</li>    <li>Mt Gox's Web site was blank this morning and all its tweets have been deleted. Since the start of this month, customers had been unable to withdraw their bitcoins. On Sunday, CEO Mark Karpeles resigned from the board of the Bitcoin Foundation.</li>    <li>One rumor, based on a leaked document, is that 744,400 bitcoins worth $350M have been stolen from Mt Gox, or 6% of all bitcoins in existence.</li>    <li>Six other major bitcoin exchanges and businesses have said they'll work together to reassure customers about the security of their funds.</li>    <li>Meanwhile, security firm Trustwave yesterday said hundreds of thousands of computers <a href=\"http://www.reuters.com/article/2014/02/24/us-bitcoin-security-idUSBREA1N1JO20140224\" target=\"_blank\">have been infected</a> with a virus called \"Pony\" that allows thieves to steal digital currencies such as bitcoins.</li>\n<li>ETFs: BITCN, TUCND</li> </ul><div class=\"tiny-share-widget\" data-id=\"1588303\" data-linked=\"Bitcoin plunges as major exchange goes dark\" data-tweet=\"$BTCS $COIN $BTCS - Bitcoin plunges as major exchange goes dark https://seekingalpha.com/news/1588303-bitcoin-plunges-as-major-exchange-goes-dark?source=tweet\" data-url=\"https://seekingalpha.com/news/1588303-bitcoin-plunges-as-major-exchange-goes-dark\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1588293\" data-ts=\"1393319988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1588293-yuan-ceases-to-be-one-way-bet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yuan ceases to be one-way bet</a></h4><ul>   <li>The Chinese yuan has fallen for the <a href=\"http://www.bloomberg.com/news/2014-02-25/yuan-drops-most-since-2012-on-speculation-pboc-wants-volatility.html\" target=\"_blank\">sixth day in a row</a> and hit its lowest level in a year, with currency analyst Kenix Lai believing that the People's Bank of China has been engineering the fall, possibly to \"change the perception of the one-way bet on yuan gains.\"</li>    <li>Lai says the PBOC may also be \"introducing two-way volatility as it prepares the renminbi for a wider trading band.\" The PBOC said last week that it plans to expand the range in an \"orderly\" manner.</li>    <li>The yuan's direction has generally been upwards, but since touching a record high against the dollar in mid-January, the currency has dropped over 1%.</li>    <li>Today, the PBOC set the renminbi's daily reference rate at 6.1184 to the dollar. The yuan is allowed to trade 1% either side of the rate.</li>    <li>The Shanghai Composite closes <font color=\"red\">-2%</font>.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a>, <a href=\"https://seekingalpha.com/symbol/pgj\" title=\"PowerShares Golden Dragon China Portfolio ETF\">PGJ</a>, <a href=\"https://seekingalpha.com/symbol/gxc\" title=\"SPDR S&amp;P China ETF\">GXC</a>, <a href=\"https://seekingalpha.com/symbol/fxp\" title=\"ProShares UltraShort FTSE China 25 ETF\">FXP</a>, <a href=\"https://seekingalpha.com/symbol/yinn\" title=\"Direxion Daily FTSE China Bull 3X Shares ETF\">YINN</a>, <a href=\"https://seekingalpha.com/symbol/hao\" title=\"Guggenheim China Small Cap ETF \">HAO</a>, <a href=\"https://seekingalpha.com/symbol/kweb\" title=\"KraneShares CSI China Internet ETF\">KWEB</a>, <a href=\"https://seekingalpha.com/symbol/ashr\" title=\"db X-trackers Harvest China ETF\">ASHR</a>, <a href=\"https://seekingalpha.com/symbol/chiq\" title=\"Global X China Consumer ETF\">CHIQ</a>, <a href=\"https://seekingalpha.com/symbol/tao\" title=\"Guggenheim China Real Estate ETF \">TAO</a>, <a href=\"https://seekingalpha.com/symbol/chix\" title=\"Global X China Financial ETF\">CHIX</a>, <a href=\"https://seekingalpha.com/symbol/dsum\" title=\"PowerShares Chinese Yuan Dim Sum Bond Portfolio ETF\">DSUM</a>, <a href=\"https://seekingalpha.com/symbol/yang\" title=\"Direxion Daily FTSE China Bear 3x Shares ETF\">YANG</a>, <a href=\"https://seekingalpha.com/symbol/cqqq\" title=\"Guggenheim China Technology ETF \">CQQQ</a>, <a href=\"https://seekingalpha.com/symbol/mchi\" title=\"iShares MSCI China ETF\">MCHI</a>, <a href=\"https://seekingalpha.com/symbol/pek\" title=\"Market Vectors ChinaAMC A-Share ETF\">PEK</a>, <a href=\"https://seekingalpha.com/symbol/qqqc\" title=\"Global X China Technology ETF\">QQQC</a>, <a href=\"https://seekingalpha.com/symbol/xpp\" title=\"ProShares Ultra FTSE China 25 ETF\">XPP</a>, <a href=\"https://seekingalpha.com/symbol/yao\" title=\"Guggenheim China All-Cap ETF \">YAO</a>, <a href=\"https://seekingalpha.com/symbol/chxx\" title=\"EGShares China Infrastructure ETF\">CHXX</a>, <a href=\"https://seekingalpha.com/symbol/chii\" title=\"Global X China Industrial ETF\">CHII</a>, <a href=\"https://seekingalpha.com/symbol/chxf\" title=\"WisdomTree China Dividend ex-Financials ETF\">CHXF</a>, <a href=\"https://seekingalpha.com/symbol/yxi\" title=\"ProShares Short FTSE China 25 ETF\">YXI</a>, <a href=\"https://seekingalpha.com/symbol/ecns\" title=\"iShares MSCI China Small-Cap ETF\">ECNS</a>, <a href=\"https://seekingalpha.com/symbol/chie\" title=\"Global X China Energy ETF\">CHIE</a>, <a href=\"https://seekingalpha.com/symbol/chim\" title=\"Global X China Materials ETF\">CHIM</a>, <a href=\"https://seekingalpha.com/symbol/fca\" title=\"First Trust China AlphaDEX ETF\">FCA</a>, <a href=\"https://seekingalpha.com/symbol/kfyp\" title=\"KraneShares CSI China Five Year Plan ETF\">KFYP</a>, <a href=\"https://seekingalpha.com/symbol/chlc\" title=\"Market Vectors Renminbi Bond ETF\">CHLC</a>, <a href=\"https://seekingalpha.com/symbol/tchi\" title=\"RBS China Trendpilot ETN\">TCHI</a>, <a href=\"https://seekingalpha.com/symbol/chna\" title=\"PowerShares China A - Share Portfolio ETF\">CHNA</a>, <a href=\"https://seekingalpha.com/symbol/cew\" title=\"WisdomTree Emerging Currency ETF\">CEW</a>, <a href=\"https://seekingalpha.com/symbol/jem\" title=\"iPath GEMS Index ETN\">JEM</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1588293\" data-linked=\"Yuan ceases to be one-way bet\" data-tweet=\"$FXI $PGJ $GXC - Yuan ceases to be one-way bet https://seekingalpha.com/news/1588293-yuan-ceases-to-be-one-way-bet?source=tweet\" data-url=\"https://seekingalpha.com/news/1588293-yuan-ceases-to-be-one-way-bet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":60,"message":null,"success":true,"today":{"start":1576904400,"end":1576990799,"str":"Saturday, December 21, 2019"},"yesterday":{"start":1576818000,"end":1576904399}}